<SEC-DOCUMENT>0001193125-21-327421.txt : 20211112
<SEC-HEADER>0001193125-21-327421.hdr.sgml : 20211112
<ACCEPTANCE-DATETIME>20211112081626
ACCESSION NUMBER:		0001193125-21-327421
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20211112
DATE AS OF CHANGE:		20211112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAIN CELESTIAL GROUP INC
		CENTRAL INDEX KEY:			0000910406
		STANDARD INDUSTRIAL CLASSIFICATION:	FOOD & KINDRED PRODUCTS [2000]
		IRS NUMBER:				223240619
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-260959
		FILM NUMBER:		211399835

	BUSINESS ADDRESS:	
		STREET 1:		1111 MARCUS AVENUE
		CITY:			LAKE SUCCESS
		STATE:			NY
		ZIP:			11042
		BUSINESS PHONE:		5165875000

	MAIL ADDRESS:	
		STREET 1:		1111 MARCUS AVENUE
		CITY:			LAKE SUCCESS
		STATE:			NY
		ZIP:			11042

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HAIN FOOD GROUP INC
		DATE OF NAME CHANGE:	19941219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KINERET ACQUISITION CORP
		DATE OF NAME CHANGE:	19931021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	21ST CENTURY FOOD PRODUCTS CORP
		DATE OF NAME CHANGE:	19930830
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d253634d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(7) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No. 333-260959 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class of securities</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount to be<BR>registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed maximum<BR>aggregate offering<BR>price per share (1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed maximum<BR>aggregate offering<BR>price (1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>registration fee (2)</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, $0.01 par value per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">12,379,504</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$43.16</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$534,299,392.64</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$49,529.55</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) and
Rule 456(b) under the Securities Act of 1933, as amended, based on the average of the high and low share prices of the Common Stock on November 11, 2021, as reported on the NASDAQ Global Select Market. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman"><B>(To Prospectus dated November&nbsp;10, 2021) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>12,379,504 Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g253634g01a02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>The Hain Celestial Group, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">This prospectus supplement
relates to the resale of 12,379,504 shares of common stock, $0.01 par value per share, of The Hain Celestial Group, Inc. (the &#147;Common Stock&#148;). All of the shares of our Common Stock in this offering are being offered by the selling
shareholders (the &#147;Selling Shareholders&#148;) identified in this prospectus supplement. We will not receive any proceeds from the sale of these shares by the Selling Shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Our Common Stock is listed on the NASDAQ Global Select Market and trades under the ticker symbol &#147;HAIN.&#148; The last reported sale price of our shares
of Common Stock on November&nbsp;9, 2021 was $47.95 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Subject to the completion of this offering, we intend to concurrently repurchase directly
from the Selling Shareholders 1,700,000 shares of our Common Stock. The price per share to be paid by us will equal the price at which Morgan Stanley&nbsp;&amp; Co. LLC (the &#147;Underwriter&#148;) will purchase the shares from the Selling
Shareholders in this offering, net of underwriting discounts and commissions. This offering is not conditioned upon the completion of the share repurchase. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><B>Investing in our common
stock involves risks. Please read &#147;<A HREF="#supptoc253634_4">Risk Factors</A>&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-6</FONT> of this prospectus supplement and in the documents incorporated by reference into this
prospectus supplement. You should carefully consider these risk factors and risks before deciding to purchase any Common Stock. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman"><B>Neither the
Securities and Exchange Commission nor any state securities commission has approved or disapproved these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the
contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">563,267,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Underwriting discount(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,189,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Proceeds to the Selling Shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">557,077,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriting&#148; beginning on page <FONT STYLE="white-space:nowrap">S-13</FONT> of this prospectus
supplement for additional information regarding total underwriting compensation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Delivery of the shares of Common Stock is expected to
be made on or about November&nbsp;15, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Morgan
Stanley </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus supplement is November&nbsp;10, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-i</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_2">FORWARD LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_3">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_6">SELLING SHAREHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_7">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_8">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_9">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_10">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_11">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc253634_12">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_2">THE HAIN CELESTIAL GROUP, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_4">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_6">SELLING SECURITY HOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_7">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_8">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_9">DESCRIPTION OF PREFERRED STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_10">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_11">DESCRIPTION OF OTHER SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_14">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_15">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document consists of two parts. The first part is this prospectus supplement, which describes the terms of this offering of our Common
Stock and adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into the accompanying prospectus. The second part is the accompanying prospectus, dated November&nbsp;10, 2021, which
gives more general information, some of which may not apply to this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the Company, the Selling Shareholders or the
Underwriter have authorized anyone to provide any information other than that contained in this prospectus supplement and the accompanying prospectus or incorporated by reference in this prospectus supplement and the accompanying prospectus or in
any free writing prospectus prepared by or on behalf of us to which we have referred you. If anyone provides you with different or inconsistent information, you should not rely on it. None of the Company, the Selling Shareholders or the Underwriter
take responsibility for, and can provide assurance as to the reliability of, any other information that others may give you. The Selling Shareholders are not making an offer of these securities in any jurisdiction where the offer is not permitted.
You should not assume that the information contained in this prospectus supplement and the accompanying prospectus or incorporated by reference in this prospectus supplement and the accompanying prospectus is accurate as of any date other than the
date of such document. Our business, financial condition, results of operations and prospects may have changed since those dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in this prospectus to &#147;the Company,&#148; &#147;we,&#148; &#147;our&#148; and &#147;us&#148; or other similar terms mean The
Hain Celestial Group, Inc. and its wholly owned subsidiaries, unless we state otherwise or the context indicates otherwise. References to the &#147;Selling Shareholders&#148; refer to the selling shareholders identified in the table in the section
entitled &#147;Selling Shareholders&#148; in this prospectus supplement. References to the &#147;SEC&#148; refer to the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is important for you to read and consider all information contained in this prospectus supplement and the accompanying prospectus,
including the documents incorporated by reference herein, in making your investment decision. You should also read and consider the information in the documents to which we have referred you in the sections entitled &#147;Where You Can Find More
Information&#148; and &#147;Incorporation of Certain Documents by Reference&#148; in this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
supplement may add to, update or change the information in the accompanying prospectus. To the extent any inconsistency or conflict exists between the information included or incorporated by reference in this prospectus supplement and the
information included or incorporated by reference in the accompanying prospectus, the information included or incorporated by reference in this prospectus supplement updates and supersedes the information in the accompanying prospectus or the
information included or incorporated by reference in this prospectus supplement. In addition, any statement in a filing we make with the SEC that adds to, updates or changes information contained in an earlier filing we made with the SEC shall be
deemed to modify and supersede such information in the earlier filing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_2"></A>FORWARD LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus and the information incorporated or deemed to be incorporated by reference in this
prospectus supplement and the accompanying prospectus may include forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933 (&#147;the Securities Act&#148;), and Section&nbsp;21E of the Exchange Act and the
Private Securities Litigation Reform Act of 1995. We make such forward-looking statements pursuant to the &#147;safe harbor&#148; provisions of the Private Securities Litigation Reform Act of 1995. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All statements included or incorporated or deemed to be incorporated by reference into this prospectus supplement and the accompanying
prospectus, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Such statements involve
risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words
&#147;believe,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;may,&#148; &#147;should,&#148; &#147;plan,&#148; &#147;intend,&#148; &#147;potential,&#148; &#147;will&#148; and similar expressions are intended to identify such forward-looking
statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives, business strategy, supply chain, brand
portfolio and product performance; the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; current or future macroeconomic trends; and future corporate acquisitions or dispositions. We undertake no obligation to further update forward-looking
statements, or the risk factors described &#147;Risk Factors&#148; in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended June&nbsp;30, 2021, to reflect actual results or changes in assumptions or
circumstances, except as required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements included or incorporated or deemed to be incorporated
by reference into this prospectus supplement and the accompanying prospectus do not constitute guarantees or promises of future performance. Risks and uncertainties that may cause actual results to differ materially from forward-looking statements
include: challenges and uncertainty resulting from the impact of competition; challenges and uncertainty resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; our ability to manage our supply chain effectively; disruption of
operations at our manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences; customer concentration; reliance on independent distributors; the availability of organic ingredients; risks associated with
our international sales and operations; risks associated with outsourcing arrangements; our ability to execute our cost reduction initiatives and related strategic initiatives; our reliance on independent certification for a number of our products;
the reputation of our Company and our brands; our ability to use and protect trademarks; general economic conditions; input cost inflation; the United Kingdom&#146;s exit from the European Union; cybersecurity incidents; disruptions to information
technology systems; the impact of climate change; liabilities, claims or regulatory change with respect to environmental matters; potential liability if our products cause illness or physical harm; the highly regulated environment in which we
operate; pending and future litigation; compliance with data privacy laws; compliance with our credit agreement; the discontinuation of LIBOR; concentration in the ownership of our common stock; our ability to issue preferred stock; the adequacy of
our insurance coverage; impairments in the carrying value of goodwill or other intangible assets; and other risks described under &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year
ended June&nbsp;30, 2021 as well as in other reports that we file in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cautioned not to rely unduly on any
forward-looking statements. The risks and uncertainties related to any forward-looking statements are discussed in more detail under the &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations&#148; sections of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2021 and our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended
September&nbsp;30, 2021 and other documents on file with the SEC. You may obtain copies of these documents as described under &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Information by Reference&#148; in this
prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_3"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights information contained in or incorporated by reference in this prospectus supplement and the accompanying
prospectus. Because it is a summary, it may not contain all of the information that may be important to you. Before making a decision to invest in our Common Stock, you should read carefully this entire prospectus supplement and the accompanying
prospectus, including the section entitled &#147;Where You Can Find More Information&#148; and the section entitled &#147;Risk Factors&#148; beginning on page <FONT STYLE="white-space:nowrap">S-6</FONT> of this prospectus supplement and in the
documents incorporated by reference into this prospectus supplement and the accompanying prospectus. This summary is qualified in its entirety by the more detailed information and financial statements, including the notes thereto, incorporated by
reference into this prospectus supplement and the accompanying prospectus. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Founded in 1993, we are a Delaware corporation and are headquartered in Lake Success, New York. Our mission has continued to evolve since our
founding, with health and wellness being the core tenet. We continue to be a leading marketer, manufacturer and seller of organic and natural, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;better-for-you&#148;</FONT></FONT>
products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. We are committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing
processes. We sell our products through specialty and natural food distributors, supermarkets, natural food stores, mass market and <FONT STYLE="white-space:nowrap">e-commerce</FONT> retailers, food service channels and club, drug and convenience
stores in over 80 countries worldwide. We operate under two reportable segments: North America and International. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We manufacture, market,
distribute and sell organic and natural products under brand names that are sold as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;better-for-you&#148;</FONT></FONT> products, providing consumers with the opportunity to lead
A Healthier Way of Life<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. We are a leader in many organic and natural products categories, with many recognized brands in the various market categories we serve, including Celestial Seasonings<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Clarks<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, Cully&nbsp;&amp; Sully<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Earth&#146;s Best<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Ella&#146;s Kitchen<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Frank Cooper&#146;s<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Gale&#146;s<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Garden of Eatin&#146;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hain Pure Foods<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hartley&#146;s<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Health Valley<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Imagine<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,
Joya<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Lima<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Linda McCartney&#146;s<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;(under license), MaraNatha<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Natumi<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, New Covent Garden Soup Co.<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Robertson&#146;s<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Rose&#146;s<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>(under license), Sensible Portions<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Spectrum<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, <FONT STYLE="white-space:nowrap">Sun-Pat</FONT><SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Terra<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, The Greek Gods<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Yorkshire Provender<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Yves Veggie Cuisine<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. Our personal care products are marketed under the Alba Botanica<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Avalon
Organics<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, JASON<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Live Clean<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, and Queen Helene<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;brands. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since fiscal 2019, we have been executing the four key pillars of our
strategy&#151;(1) simplify our portfolio; (2)&nbsp;strengthen our capabilities; (3)&nbsp;expand profit margins and cash flow; and (4)&nbsp;reinvigorate profitable topline growth&#151;which we refer to as Hain 2.0. This strategy, which is on schedule
to be completed ahead of our planned timeline, has laid the foundation for Hain 3.0, our vision and strategy for the next several years, which is about building a global healthy food and beverage company with industry-leading top line growth. We
believe Hain 3.0 positions us as an advantaged and differentiated company, as compared to others in the food industry for several reasons: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are singularly focused on health and wellness, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are a global company in high-growth categories with opportunities for expansion in existing and new channels
and geographies, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have unique and advantaged brands with strong points of difference, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">given our size, small wins can drive material incremental growth. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have <FONT STYLE="white-space:nowrap">re-segmented</FONT> the brand portfolio with a more
global view to where we have the most growth potential. As a result, we are migrating from a strategy focused on rejuvenating North America behind a construct of &#147;Get Bigger&#148; and &#147;Get Better&#148; brand categories to one that focuses
on growing global brands in categories where we think we have the most potential. The categories we have identified are called Turbocharge Growth, Targeted Investment, and Fuel: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The <I>Turbocharge Growth</I> brands are leading-share brands in very high-growth categories. The Turbocharge
Growth brands are made up of plant-based meat and <FONT STYLE="white-space:nowrap">non-dairy</FONT> beverages as well as snacks. Our meat and dairy alternatives are concentrated outside the United States, while the snacks businesses include brands
both within the United States and in International. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The <I>Targeted Investment</I> brands are made up of leading-share brands in lower-growth categories. To date, we
have demonstrated our ability to drive market share and reinvigorate these categories, and we expect that we can continue to do this in the future. The Targeted Investment brands are made up of tea, baby, yogurt, and personal care. In contrast with
Hain 2.0, baby is now one of our growth focus areas, due to its strong brands, scale, profitability, and growth prospects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The <I>Fuel</I> brands are stable brands that will be leveraged to fuel investment in the Turbocharge Growth and
Targeted Investment categories. Fuel brands are made up of premium pantry brands with scale, in categories such as soup, cooking oils and nut butters. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, as part of Hain 3.0, we will continue to simplify our brand portfolio as we continue to identify brands that are declining and
have low margins. The <I>Simplify</I> brands are subscale declining businesses that have limited long-term potential for the Company, and therefore will be managed for profit until they are potentially divested, likely over the course of the next
several years. Acquisitions are expected to play a role in Hain 3.0 and part of our capital allocation strategy is focused on actively looking for targets in the market. As we continue to simplify and stabilize the organization and consolidate sales
into fewer priority categories, we are well-positioned and expect to make targeted acquisitions supported by our borrowing capacity to help us further strengthen our position in those categories. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 1111 Marcus Avenue, Lake Success, NY 11042. Our telephone number is <FONT
STYLE="white-space:nowrap">(516)&nbsp;587-5000.</FONT> Our public website is www.hain.com. On our website, investors can find press releases, financial filings and other information about us. The SEC&#146;s website, www.sec.gov, also offers access
to reports and documents we have electronically filed with or furnished to the SEC. These website addresses are not intended to function as hyperlinks, and the information contained on our website and in the SEC&#146;s website is not intended to be
a part of this prospectus or any accompanying prospectus supplement. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHARE REPURCHASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the completion of the offering, we intend to concurrently repurchase directly from the Selling Shareholders 1,700,000 shares of our
Common Stock. The price per share to be paid by us will equal the price at which the Underwriter will purchase the shares from the Selling Shareholders in this offering, net of underwriting discounts and commissions, which is $45.00 per share. We
refer to this transaction as the &#147;share repurchase.&#148; The aggregate repurchase price will be $76.5 million. The share repurchase will be made under our August 2021 repurchase authorization, pursuant to which our board of directors
authorized the repurchase of up to $300&nbsp;million of our issued and outstanding common stock. We will have approximately $130.3 million remaining under our August 2021 repurchase authorization after the consummation of the share repurchase in
connection with this offering. The closing of the share repurchase will be conditioned upon the closing of this offering and therefore there can be no assurance that the share repurchase will be completed. This offering is not conditioned upon the
completion of the share repurchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to fund the share repurchase with borrowings under our revolving credit facility. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Selling Shareholders </P></TD>
<TD>Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> VI, LP </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-B,</FONT> LP </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-C,</FONT> LP </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-D,</FONT> LP </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-E,</FONT> LP </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Selling Shareholders are <FONT STYLE="white-space:nowrap">co-investment</FONT> funds managed by Engaged Capital, LLC (&#147;Engaged Capital&#148;), and the sale of their shares in this offering is related to the
required wind down of the <FONT STYLE="white-space:nowrap">co-investment</FONT> funds. Engaged Capital has informed the Company that the Company will remain one of the largest positions in Engaged Capital&#146;s portfolio after the offering and that
the sale of shares is not an indication of Engaged Capital&#146;s view on the future prospects of the Company. Engaged Capital will continue to hold 1,900,792 shares of the Company&#146;s common stock that is not being sold in this offering. Glenn
W. Welling, the Founder and Chief Investment Officer of Engaged Capital, will continue to serve as a director of the Company after this offering. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shares of Common Stock being offered by the Selling Shareholders </P></TD>
<TD>12,379,504 shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Concurrent share repurchase </P></TD>
<TD>Subject to the completion of this offering, we intend to concurrently repurchase directly from the Selling Shareholders 1,700,000 shares of our Common Stock. The price per share to be paid by us will equal the price at which the Underwriter will
purchase the shares from the Selling Shareholders in this offering, net of underwriting discounts and commissions. The closing of the share repurchase will be conditioned on the closing of this offering. This offering is not conditioned upon the
completion of the share repurchase. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shares of Common Stock outstanding after this&nbsp;offering<SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP> </P></TD>
<TD>94,581,455 shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>The Selling Shareholders will receive the net proceeds from this offering. We will not receive any proceeds from the Selling Shareholders&#146; sale of the shares of Common Stock described in the </TD></TR></TABLE>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The number of shares of Common Stock outstanding after the completion of this offering above and elsewhere in
this prospectus supplement is based on 94,581,455 shares of Common Stock outstanding as of November&nbsp;2, 2021 and excludes (i)&nbsp;shares issuable upon exercise of outstanding options or vesting and settlement of equity awards and shares
reserved for future issuance under any employee stock option, stock bonus, equity incentive plan, restricted share units agreement, performance units agreement or other stock plan or arrangement and (ii)&nbsp;the impact of the concurrent share
repurchase. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman">
prospectus supplement and the accompanying prospectus. See &#147;Use of Proceeds&#148; and &#147;Selling Shareholders&#148; in this prospectus supplement. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD>Investing in our Common Stock involves risks and the purchaser of our shares of Common Stock may lose their entire investment. See &#147;Risk Factors&#148; beginning on page <FONT STYLE="white-space:nowrap">S-6</FONT> of this prospectus
supplement and the sections entitled &#147;Risk Factors&#148; in the accompanying prospectus and the documents incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of the risk factors you should
carefully consider before deciding to investment in our Common Stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Ticker Symbol </P></TD>
<TD>Our Common Stock is listed on the NASDAQ Global Select Market under the symbol &#147;HAIN.&#148; </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in shares of our Common Stock involves risks. Prior to making a decision about investing in shares of our Common Stock, you should
carefully consider the risk factors discussed under the heading &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2021, are incorporated herein by reference.
The risks and uncertainties we have described are not the only risks we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. If any of these risks actually occurs,
our business, results of operations and financial condition could suffer. In that case, the trading price of our Common Stock could decline, and you could lose part of your investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to this Offering and Ownership of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The price of our Common Stock may fluctuate and you could lose all or a significant part of your investment. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Volatility in the market price of our Common Stock may prevent you from being able to sell your shares at or above the price you paid. The
market price of our Common Stock may also be influenced by many factors, some of which are beyond our control, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of competition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in quarterly operating results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general economic conditions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">war, terrorist acts and epidemic disease; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investor perceptions of us and our industry; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the other risk factors discussed in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the fiscal year ended June&nbsp;30, 2021. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock market in general is subject to extreme price and
volume fluctuations that may be unrelated or disproportionate to the operating performance of companies like us. These broad market and industry factors may materially reduce the market price of our Common Stock, regardless of our operating
performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the Selling Shareholders&#146; sale of the shares of Common Stock described in this prospectus
supplement and the accompanying prospectus. Any shares of Common Stock offered by the Selling Shareholders pursuant to this prospectus supplement and the accompanying prospectus will be sold by the Selling Shareholders for their own accounts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_6"></A>SELLING SHAREHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above, the Selling Shareholders have agreed to sell to the Underwriter 12,397,504 shares of our Common Stock, which we are
registering for resale by them and which are covered by this prospectus supplement and the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table
and accompanying footnote show information with respect to the beneficial ownership of our Common Stock, as of November&nbsp;2, 2021, held by the Selling Shareholders. The percentage below for Common Stock owned before the offering is based on
94,581,455 shares of our Common Stock outstanding as of November&nbsp;2, 2021. Beneficial ownership is determined under the SEC rules and regulations and generally includes voting or investment power over securities. Except as indicated in the
footnote to this table, we believe that the Selling Shareholders identified in the table below possess sole voting and investment power over all shares of equity securities shown as beneficially owned by the Selling Shareholders. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficial Ownership<BR>Prior to Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially Owned<BR>After Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of<BR>Outstanding<BR>Common<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Being<BR>Offered</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of<BR>Outstanding<BR>Common<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> VI, LP(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,106,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,086,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.02</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT>
<FONT STYLE="white-space:nowrap">VI-B,</FONT> LP(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,311,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,291,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.02</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT>
<FONT STYLE="white-space:nowrap">VI-C,</FONT> LP(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,407,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,397,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.01</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT>
<FONT STYLE="white-space:nowrap">VI-D,</FONT> LP(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,096,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,096,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT>
<FONT STYLE="white-space:nowrap">VI-E,</FONT> LP(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,207,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.45</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,507,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,700,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.80</TD>
<TD NOWRAP VALIGN="bottom">%(2)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Engaged Capital, as the general partner and investment adviser of Engaged Capital <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> VI, LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-B,</FONT> LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT
STYLE="white-space:nowrap">VI-C,</FONT> LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-D,</FONT> LP and Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT
STYLE="white-space:nowrap">VI-E,</FONT> LP, may be deemed to beneficially own the 14,129,504 shares owned in the aggregate by Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> VI, LP, Engaged Capital
<FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-B,</FONT> LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-C,</FONT> LP, Engaged Capital <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-D,</FONT> LP and Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-E,</FONT> LP. Engaged Capital Holdings, LLC, as
the managing member of Engaged Capital, may be deemed to beneficially own the 14,129,504 shares owned in the aggregate by Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> VI, LP, Engaged Capital
<FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-B,</FONT> LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-C,</FONT> LP, Engaged Capital <FONT
STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-D,</FONT> LP and Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-E,</FONT> LP. Glenn W. Welling, as the Founder and
Chief Investment Officer of Engaged Capital and the sole member of Engaged Capital Holdings, LLC, may be deemed to beneficially own the 14,129,504 shares owned in the aggregate by Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> VI,
LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-B,</FONT> LP, Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-C,</FONT> LP, Engaged
Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-D,</FONT> LP and Engaged Capital <FONT STYLE="white-space:nowrap">Co-Invest</FONT> <FONT STYLE="white-space:nowrap">VI-E,</FONT> LP. Mr.&nbsp;Welling has
been a director of the Company since September 2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the 1,700,000 shares of Common Stock that the Company intends to concurrently repurchase directly
from the Selling Shareholders subject to the completion of this offering. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_7"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material U.S. federal income tax considerations related to the ownership and disposition of our Common Stock
by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, as defined below, that acquires our Common Stock pursuant to this offering. This discussion assumes that a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will hold our Common
Stock acquired pursuant to this offering as a capital asset within the meaning of Section&nbsp;1221 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) (generally, for investment purposes). This summary does not address all
aspects of U.S. federal income taxation that may be relevant to a particular investor in light of the investor&#146;s individual circumstances and does not purport to be a complete analysis of all the potential tax considerations relating thereto.
In addition, this discussion does not address (i)&nbsp;other U.S. federal tax laws, such as estate and gift tax laws, the alternative minimum tax or the Medicare tax imposed on net investment income, (ii)&nbsp;state, local or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences or (iii)&nbsp;the special tax rules that may apply to certain investors, including, without limitation, banks, insurance companies, financial institutions, controlled foreign corporations,
passive foreign investment companies, corporations that accumulate earnings to avoid U.S. federal income tax, broker-dealers, traders in securities, grantor trusts, personal holding companies, persons who have elected
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> accounting, persons subject to special tax accounting rules as a result of any item of gross income with respect to our Common Stock being taken into
account in an applicable financial statement, persons that acquire, hold or dispose of our Common Stock as part of a straddle, hedge, constructive sale, conversion or other integrated or risk reduction transaction,
<FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities, regulated investment companies, real estate investment trusts, persons deemed to sell our Common Stock under the constructive sale provisions of the Code, persons who hold or receive our
Common Stock pursuant to the exercise of any employee stock option or otherwise as compensation, entities or arrangements classified as partnerships for U.S. federal income tax purposes or other pass-through entities (or an investor in such entities
or arrangements), pension plans, &#147;qualified foreign pension funds&#148; as defined in Section&nbsp;897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension funds or U.S. expatriates and former
long-term residents of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is based on current provisions of the Code, applicable Treasury regulations
promulgated thereunder, judicial opinions, and published rulings of the Internal Revenue Service (the &#147;IRS&#148;), all as in effect on the date of this prospectus and all of which are subject to differing interpretations or change, possibly
with retroactive effect. We have not sought, and will not seek, any ruling from the IRS or any opinion of counsel with respect to the tax consequences discussed herein, and there can be no assurance that the IRS will not take a position contrary to
the tax consequences discussed below or that any position taken by the IRS would not be sustained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this discussion, the term
&#147;U.S. person&#148; means a person that is, for U.S. federal income tax purposes, (i)&nbsp;a citizen or individual resident of the United States, (ii)&nbsp;a corporation created or organized in the United States or under the laws of the United
States or any state thereof or the District of Columbia, (iii)&nbsp;an estate the income of which is subject to U.S. federal income taxation regardless of its source or (iv)&nbsp;a trust if (A)&nbsp;a court within the United States is able to
exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (B)&nbsp;it has in effect a valid election under applicable Treasury regulations
to be treated as a U.S. person. As used in this summary, the term <FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; means a beneficial owner of our Common Stock that is, for U.S. federal income tax purposes, an individual,
corporation, estate or trust that is not a U.S. person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tax treatment of a partnership (or any other entity or arrangement treated as
a partnership for U.S. federal income tax purposes) that holds our Common Stock and each partner thereof will generally depend upon the status and activities of the partnership and such partner. A holder that is treated as a partnership for U.S.
federal income tax purposes or a partner in such partnership should consult its own tax advisor regarding the U.S. federal income tax consequences applicable to it and its partners of the ownership and disposition of our Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS ONLY A SUMMARY OF THE MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS RELATED TO THE
OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK BY CERTAIN <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES OF
THE OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL AND <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAX LAWS, AS WELL AS U.S. FEDERAL ESTATE AND GIFT TAX LAWS AND ANY APPLICABLE TAX
TREATY. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material U.S. Federal Income Tax Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distributions on Common Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
we pay cash or distribute property to holders of shares of Common Stock, such distributions generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as
determined under U.S. federal income tax principles. Distributions in excess of current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s adjusted tax basis in our Common Stock, and to the extent the amount of the distribution exceeds a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s adjusted tax basis in our
Common Stock, will be treated as gain from the sale or exchange of the Common Stock and will be treated as described under &#147;&#151;Gain on Sale, Exchange or Other Taxable Disposition of Common Stock&#148; below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to withholding of U.S. federal income
tax at a rate of 30% of the gross amount of the dividend or such lower rate as may be specified by an applicable income tax treaty. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that wishes to claim the benefit of an applicable tax
treaty withholding rate generally will be required to (i)&nbsp;duly complete and execute an IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or an IRS Form
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or any successor form of the foregoing) and certify under penalties of perjury that such holder is not a U.S. person and is eligible for the benefits of the
applicable tax treaty or (ii)&nbsp;if our Common Stock is held through certain foreign intermediaries, satisfy the relevant certification requirements of applicable Treasury regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends that are effectively connected with a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business
in the United States (and, if required by an applicable income tax treaty, attributable to a permanent establishment or fixed base maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States) generally are subject
to U.S. federal income tax on a net income basis at the U.S. federal income tax rates generally applicable to a U.S. person and are not subject to withholding of U.S. federal income tax, provided that the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder establishes an exemption from such withholding by complying with certain certification and disclosure requirements (generally by providing a duly completed and executed IRS Form <FONT
STYLE="white-space:nowrap">W-8ECI</FONT> (or any successor form thereof)). Any such effectively connected dividends (and, if required, dividends attributable to a U.S. permanent establishment or fixed base) received by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder that is treated as a foreign corporation for U.S. federal income tax purposes may be subject to an additional branch profits tax at a 30% rate, or such lower rate as may be specified by an applicable
income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder eligible for a reduced rate of withholding of U.S. federal
income tax pursuant to an income tax treaty may be able to obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their
own tax advisors regarding their entitlement to benefits under an applicable income tax treaty and the manner of claiming the benefits of such treaty. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gain on Sale, Exchange or Other Taxable Disposition of Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the summary below regarding backup withholding and FATCA (as defined herein), any gain recognized by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder on a sale or other taxable disposition of our Common Stock generally will not be subject to U.S. federal income tax, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the gain is effectively connected with the conduct of a trade or business of the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment or fixed base of the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual who is present in the United
States for a period or periods aggregating 183 days or more in the taxable year of that disposition, and certain other conditions are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">we are or have been a United States real property holding corporation (a &#147;USRPHC&#148;) for U.S. federal
income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder held the Common Stock (the &#147;applicable period&#148;)
(subject to the discussion below regarding certain shareholders who own 5% or less of our Common Stock). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any gain
recognized by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is described in clause (i)&nbsp;generally will be subject to U.S. federal income tax at the income tax rates generally applicable to a U.S. person, and such <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder will be required to file a U.S. federal income tax return. Any gain of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is treated as a foreign corporation for U.S. federal income tax
purposes that is described in clause (i)&nbsp;above may also be subject to an additional branch profits tax at a 30% rate, or such lower rate as may be specified by an applicable income tax treaty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An individual <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is described in clause (ii)&nbsp;generally will be subject to a
flat 30% tax (or a lower applicable tax treaty rate) on the U.S.-source capital gain derived from the disposition, which may be offset by U.S.-source capital losses validly claimed during the taxable year of the disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to clause (iii), a U.S. corporation generally is a USRPHC if the fair market value of its U.S. real property interests equals or
exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. We believe that we are not currently and do not anticipate becoming a USRPHC. Even if we are
or were to become a USRPHC, gain arising from the sale or other taxable disposition by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our Common Stock will not be subject to U.S. federal income tax if our Common Stock is regularly
traded, as defined by applicable Treasury regulations, on an established securities market and such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has held at all times during the applicable period, actually or constructively, 5% or less of
our Common Stock. If a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds or held (at any time during the applicable period) more than 5% of our Common Stock and if we were a USRPHC at any time during the applicable period, such <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to U.S. federal income tax on the net gain derived from a taxable disposition at the income tax rates generally applicable to a U.S. person.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult their own tax advisors regarding the potential applicability of these rules, as well as any income tax treaty in their particular circumstances. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our Common Stock the amount
of distributions paid to such holder on our Common Stock, the tax, if any, withheld with respect to those distributions and such holder&#146;s name and address. Copies of the information returns reporting those distributions and withholding taxes
may also be made available to the tax authorities in the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a resident under the provisions of an applicable income tax treaty or agreement. Information reporting also is
generally required with respect to the proceeds from sales and other dispositions of our Common Stock to or through the U.S. office (and in certain cases, the foreign office) of a broker, unless the <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder establishes that it is not a U.S. person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under some circumstances, Treasury regulations require backup withholding of U.S. federal
income tax on reportable payments with respect to our Common Stock. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally may eliminate the requirement for backup withholding by providing certification of its foreign status, under
penalties of perjury, on a duly completed and executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable IRS Form <FONT
STYLE="white-space:nowrap">W-8</FONT> (or a substitute or successor form of the foregoing), or by otherwise establishing an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, backup withholding and information reporting may apply if either we or our paying agent has actual knowledge,
or reason to know, that a holder is a U.S. person. Backup withholding is not an additional tax. Rather, the amount of any backup withholding will be allowed as a credit against a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S.
federal income tax liability, if any, and may entitle such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder to a refund, provided that certain required information is timely furnished to the IRS.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult their own tax advisors regarding the application of backup withholding and the availability of and procedure for obtaining an exemption from backup withholding in their
particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FATCA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Foreign Account Tax Compliance Act, commonly referred to as &#147;FATCA,&#148; generally imposes a U.S. federal withholding tax of 30% on certain types of payments, including payments of U.S.-source dividends and gross proceeds from the sale or
other disposition of certain securities producing such U.S.-source dividends made to (i) &#147;foreign financial institutions&#148; unless they agree to collect and disclose to the IRS information regarding their direct and indirect U.S. account
holders and (ii)&nbsp;certain <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entities unless they certify certain information regarding their direct and indirect U.S. owners. Proposed Treasury regulations have been issued that would
eliminate withholding on payments of gross proceeds (but not on payments of dividends). Pursuant to the preamble to the proposed Treasury regulations, we and any withholding agent may (but are not required to) rely on this proposed change to FATCA
withholding until the final Treasury regulations are issued or the proposed Treasury regulations are withdrawn. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA
may be subject to different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not pay any additional amounts to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders in
respect of any amounts withheld, including pursuant to FATCA. Under certain circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder might be eligible for refunds or credits of such taxes.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult with their own tax advisors regarding the effect, if any, of the FATCA provisions to them based on their particular circumstances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_8"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Morgan Stanley &amp; Co. LLC is acting as underwriter of the offering. Subject to the terms and conditions set forth in an underwriting
agreement among us, the Selling Shareholders and the Underwriter, the Selling Shareholders have agreed to sell to the Underwriter, and the Underwriter has agreed to purchase from the Selling Shareholders, 12,379,504 shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, the Underwriter has agreed to purchase all of the shares of
Common Stock sold under the underwriting agreement if any of these shares are purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering is being made in the United States.
The shares of Common Stock will be offered in the United States through the Underwriter, either directly or indirectly, through its U.S. broker-dealer affiliates or agents. Sales of shares made outside of the United States may be made by affiliates
of the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the obligations of the Underwriter are subject to certain conditions
precedent such as the receipt by the Underwriter of officers&#146; certificates and legal opinions and approval of certain legal matters by its counsel, including the validity of the shares. The underwriting agreement provides that the Underwriter
will purchase all of the shares of Common Stock. The Underwriter reserves the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. We and the Selling Shareholders have agreed to indemnify the Underwriter
and certain of its controlling persons against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the Underwriter may be required to make in respect of those liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriter initially proposes to offer part of the shares of Common Stock directly to the public at the offering price listed on the
cover page of this prospectus supplement and part to certain dealers at a price that represents a concession not in excess of $0.25 per share under the public offering price. After the initial offering of the shares of Common Stock, the offering
price and other selling terms may from time to time be varied by the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting fee is equal to the public offering
price per share of Common Stock less the amount paid by the Underwriter to the Selling Shareholders per share of Common Stock. The underwriting fee is $0.50 per share. The following table shows the per share and total underwriting discounts and
commissions to be paid to the Underwriter by the Selling Shareholders. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Paid by the Selling Shareholders </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$0.50</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$6,189,752</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the total expenses of this offering, including registration, filing and listing fees,
printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $606,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock is listed on the NASDAQ Global Select Market under the trading symbol &#147;HAIN.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stabilization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this
offering, the Underwriter may engage in stabilizing transactions, which involves making bids for, purchasing and selling shares of Common Stock in the open market for the purpose of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preventing or retarding a decline in the market price of the Common Stock while this offering is in progress. These stabilizing transactions may include making short sales of the Common Stock,
which involves the sale by the Underwriter of a greater number of shares of Common Stock than it is required to purchase in this offering, and purchasing shares of Common Stock on the open market to cover positions created by short sales. A short
position is more likely to be created if the Underwriter is concerned that there may be downward pressure on the price of the Common Stock in the open market that could adversely affect investors who purchase in this offering. To the extent that the
Underwriter creates a short position, it will purchase shares in the open market to cover the position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriter has advised us
that, pursuant to Regulation M of the Securities Act, it may also engage in other activities that stabilize, maintain or otherwise affect the price of the Common Stock, including the imposition of penalty bids. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These activities may have the effect of raising or maintaining the market price of the Common Stock or preventing or retarding a decline in
the market price of the Common Stock, and, as a result, the price of the Common Stock may be higher than the price that otherwise might exist in the open market. Neither we, the Selling Shareholders nor the Underwriter make any representation or
prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our Common Stock. If the Underwriter commences these activities, it may discontinue them at any time. The Underwriter may carry
out these transactions on the NASDAQ Global Select Market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
agreed, subject to specified exceptions, for a period of 30 days after the date of this prospectus supplement without the prior written consent of the Underwriter, not to directly or indirectly: (i)&nbsp;sell, offer to sell, contract to sell or lend
any shares of Common Stock or options or warrants or other rights to acquire shares of Common Stock, or securities exchangeable or exercisable for or convertible into shares of Common Stock (&#147;Related Securities&#148;); (ii) effect any short
sale, or establish or increase any &#147;put equivalent position&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act) or liquidate or decrease any &#147;call equivalent position&#148; (as defined in Rule
<FONT STYLE="white-space:nowrap">16a-1(b)</FONT> under the Exchange Act) of any shares of Common Stock or Related Securities; (iii)&nbsp;pledge, hypothecate or grant any security interest in any shares of Common Stock or Related Securities;
(iv)&nbsp;in any other way transfer or dispose of any shares of Common Stock or Related Securities; (v)&nbsp;enter into any swap, hedge or similar arrangement or agreement that transfers, in whole or in part, the economic risk of ownership of any
shares of Common Stock or Related Securities, regardless of whether any such transaction is to be settled in securities, in cash or otherwise; (vi)&nbsp;announce the offering by us of any shares of Common Stock or Related Securities; (vii)&nbsp;file
any registration statement under the Securities Act in respect of any of the foregoing (other than as contemplated by the underwriting agreement with respect to the shares of Common Stock being offered by the Selling Shareholders pursuant to this
prospectus supplement); or (viii)&nbsp;publicly announce an intention to do any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Shareholders have agreed,
subject to specified exceptions, for a period of 30 days after the date of this prospectus supplement without the prior written consent of the Underwriter, not to directly or indirectly (1)&nbsp;offer, pledge, sell, contract to sell, sell any option
or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of our Common Stock or any securities convertible into or
exercisable or exchangeable for our Common Stock (including, without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by such Selling Shareholder in accordance with the rules and regulations of the SEC
and securities which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to make any offer, sale, pledge or disposition, (2)&nbsp;enter into any swap or other agreement that transfers, in whole or in part,
any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of Common Stock or such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other securities, in cash or otherwise or (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security convertible into or
exercisable or exchangeable for Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriter may, in its sole discretion and at any time or from time to time before the
termination of the <FONT STYLE="white-space:nowrap">30-day</FONT> period release all or any portion of the securities subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A prospectus
supplement and accompanying prospectus in electronic format may be made available by <FONT STYLE="white-space:nowrap">e-mail</FONT> or on the web sites or through online services maintained by the Underwriter or its affiliates. In those cases,
prospective investors may view offering terms online and may be allowed to place orders online. The Underwriter may agree with us to allocate a specific number of shares of Common Stock for sale to online brokerage account holders. Any such
allocation for online distributions will be made by the Underwriter on the same basis as other allocations. Other than the prospectus supplement and the accompanying prospectus in electronic format, the information on the Underwriter&#146;s websites
and any information contained in any other website maintained by the Underwriter is not part of this prospectus supplement and the accompanying prospectus, has not been approved and/or endorsed by us or the Underwriter and should not be relied upon
by investors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than in the United States, no action has been taken by us, the Selling Shareholders or the Underwriter that would permit a public
offering of the securities offered by this prospectus supplement in any jurisdiction where action for that purpose is required. The securities offered by this prospectus supplement and the accompanying prospectus may not be offered or sold, directly
or indirectly, nor may this prospectus supplement, the accompanying prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except
under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus supplement and the accompanying prospectus come are advised to inform themselves about
and to observe any restrictions relating to the offering and the distribution of this prospectus supplement and the accompanying prospectus. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or a
solicitation of an offer to buy any securities offered by this prospectus supplement and the accompanying prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the European Economic Area </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each Member State of the European Economic Area (each an &#147;EEA State&#148;), no shares of common stock have been offered or
will be offered pursuant to the offering to the public in that EEA State prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the competent authority in that EEA State or, where appropriate,
approved in another EEA State and notified to the competent authority in that EEA State, all in accordance with the EU Prospectus Regulation, except that it may make an offer to the public in that EEA State of any shares of common stock at any time
under the following exemptions under the EU Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any legal entity which is a qualified investor as defined under the EU Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under the EU Prospectus
Regulation), subject to obtaining the prior consent of representative for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other circumstances falling within Article 1(4) of the EU Prospectus Regulation, provided that no such
offer of the shares of common stock shall require the company or any underwriter to publish a prospectus pursuant to Article 3 of the EU Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the EU Prospectus Regulation.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in
relation to any shares of common stock in any EEA State means the communication in any form and by any means of sufficient information on the terms of the offer and the shares of common stock to be offered so as to enable an investor to decide to
purchase or subscribe the units, and the expression &#147;EU Prospectus Regulation&#148; means Regulation (EU) 2017/1129 (as amended or superseded). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to the United Kingdom, no shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom
prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the Financial Conduct Authority in accordance with the UK Prospectus Regulation, except that it may make an offer to the public in the
United Kingdom of any shares of common stock at any time under the following exemptions under the UK Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus
Regulation), subject to obtaining the prior consent of the representative for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other circumstances falling within Article 1(4) of the UK Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided that no such offer of the shares of common stock shall require the company or any underwriter to publish a prospectus pursuant to
Article 3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the
United Kingdom, the offering is only addressed to, and is directed only at, &#147;qualified investors&#148; within the meaning of Article 2(e) of the UK Prospectus Regulation, who are also (i)&nbsp;persons having professional experience in matters
relating to investments who fall within the definition of &#147;investment professionals&#148; in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#147;Order&#148;); (ii) high net worth bodies
corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order; or (iii)&nbsp;persons to whom it may otherwise lawfully be communicated (all such persons being referred to as
&#147;relevant persons&#148;). This document must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in
only with relevant persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to the
shares of common stock in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offering and any shares of common stock to be offered so as to enable an investor to decide to purchase
or subscribe for any shares of common stock, and the expression &#147;UK Prospectus Regulation&#148; means the UK version of Regulation (EU) No 2017/1129 as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, which is part of UK
law by virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in France </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this prospectus nor any other offering material relating to the shares of common stock described in this prospectus has been submitted
to the clearance procedures of the Autorit&eacute; des March&eacute;s Financiers or by the competent authority of another member state of the European Economic Area and notified to the Autorit&eacute; des March&eacute;s Financiers. The shares of
common stock have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares of common stock has been or will be: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">released, issued, distributed or caused to be released, issued or distributed to the public in France; or
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">used in connection with any offer for subscription or sale of the units to the public in France.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such offers, sales and distributions will be made in France only: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to qualified investors (<I>investisseurs qualifi&eacute;s</I>) as defined by Article 2(e) of Regulation (EU)
2017/1129, as amended and/or to a restricted circle of investors (<I>cercle restreint d&#146;investisseurs</I>) investing for their own account in accordance with Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French <I>Code
mon&eacute;taire et financier</I>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to investment services providers authorized to engage in portfolio management on behalf of third parties; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a transaction that, in accordance with article
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.411-2-II-1&deg;-or-2&deg;-or</FONT></FONT></FONT></FONT>
</FONT></FONT> 3&deg; of the French <I>Code mon&eacute;taire et financier</I> and article <FONT STYLE="white-space:nowrap">211-2</FONT> of the General Regulations (<I>R&egrave;glement G&eacute;n&eacute;ral</I>) of the <I>Autorit&eacute; des
March&eacute;s Financiers</I>, does not constitute a public offer (<I>offre au public de titres financiers</I>). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
shares of common stock may be resold directly or indirectly, only in compliance with articles <FONT STYLE="white-space:nowrap">L.411-1,</FONT> <FONT STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">L.412-</FONT> 1 and <FONT
STYLE="white-space:nowrap">L.621-8</FONT> through <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.621-8-3</FONT></FONT> of the French <I>Code mon&eacute;taire et financier</I>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Hong&nbsp;Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock may not be offered or sold in Hong&nbsp;Kong by means of any document other than (i)&nbsp;in circumstances which do
not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, Laws of Hong&nbsp;Kong), or (ii)&nbsp;to &#147;professional investors&#148; within the meaning of the Securities
and Futures Ordinance (Cap. 571, Laws of Hong&nbsp;Kong) and any rules made thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; within the meaning of the Companies (Winding Up and
Miscellaneous Provisions) Ordinance (Cap. 32, Laws of Hong&nbsp;Kong) and no advertisement, invitation or document relating to the shares of common stock may be issued or may be in the possession of any person for the purpose of issue (in each case
whether in Hong&nbsp;Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong&nbsp;Kong (except if permitted to do so under the laws of Hong&nbsp;Kong) other than with respect to
shares of common stock which are or are intended to be disposed of only to persons outside Hong&nbsp;Kong or only to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong&nbsp;Kong) and
any rules made thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Investors in Switzerland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;) or on any other stock
exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for
listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares
or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this document nor any other
offering or marketing material relating to the offering, the Company, the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be
supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection
afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective
Investors in Canada </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal
that are accredited investors, as defined in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> <I>Prospectus Exemptions</I> or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subsection 73.3(1) of the <I>Securities Act</I> (Ontario), and are permitted clients, as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;31-103</FONT> <I>Registration
Requirements, Exemptions and Ongoing Registrant Obligations</I>. Any resale of the shares of common stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities
laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or
damages if this prospectus (including any amendment or supplement thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities
legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal
advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a <FONT
STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> <I>Underwriting Conflicts</I> (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriter is
not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and
Investments Commission (&#147;ASIC&#148;), in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the &#147;Corporations Act&#148;),
and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any offer in Australia of the shares of common stock may only be made to persons (the &#147;Exempt Investors&#148;) who are
&#147;sophisticated investors&#148; (within the meaning of section 708(8) of the Corporations Act), &#147;professional investors&#148; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions
contained in section 708 of the Corporations Act so that it is lawful to offer the shares of common stock without disclosure to investors under Chapter 6D of the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months
after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or
where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares of common stock must observe such Australian <FONT STYLE="white-space:nowrap">on-sale</FONT> restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular
needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their
needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Japan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25
of 1948, as amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly,
in Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relevant time. For the purposes of this paragraph, &#147;Japanese Person&#148; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of
Japan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the shares of common stock were
not offered or sold or caused to be made the subject of an invitation for subscription or purchase and will not be offered or sold or caused to be made the subject of an invitation for subscription or purchase, and this prospectus or any other
document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares of common stock, has not been circulated or distributed, nor will it be circulated or distributed, whether directly or indirectly,
to any person in Singapore other than (i)&nbsp;to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time (the &#147;SFA&#148;)) pursuant to
Section&nbsp;274 of the SFA, (ii)&nbsp;to a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA, or any person pursuant to Section&nbsp;275(1A) of the SFA, and in accordance with the conditions
specified in Section&nbsp;275 of the SFA, or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the shares of common stock are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business
of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">securities or securities-based derivatives
contracts (each term as defined in Section&nbsp;2(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust
has acquired the shares of common stock pursuant to an offer made under Section&nbsp;275 of the SFA except: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where the transfer is by operation of law; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Section&nbsp;276(7) of the SFA. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with Section&nbsp;309B of the SFA and the Capital Markets Products (the &#147;CMP&#148;) Regulations 2018, the shares of common
stock are prescribed capital markets products (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in Monetary Authority of Singapore Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of
Investment Products and Monetary Authority of Singapore Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_9"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the Common Stock offered hereby will be passed upon for us by Cravath, Swaine&nbsp;&amp; Moore LLP, New York, New York.
Certain legal matters will be passed upon for the Underwriter by Weil, Gotshal&nbsp;&amp; Manges LLP, New York, New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_10"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of The Hain Celestial Group, Inc. and Subsidiaries (the &#147;Company&#148;) appearing in the
Company&#146;s Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended June&nbsp;30, 2021, and the effectiveness of the Company&#146;s internal control over financial reporting as of June&nbsp;30, 2021 have been audited
by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference
in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_11"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed a Form <FONT STYLE="white-space:nowrap">S-3</FONT> with the SEC under the Securities Act with respect to the Common Stock
offered by this prospectus supplement and the accompanying prospectus. You should review the information and exhibits in the registration statement for further information about us and the securities that are being offered by this prospectus
supplement and the accompanying prospectus. Statements in this prospectus supplement and the accompanying prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not
intended to be comprehensive and are qualified by reference to those filings. You should review the complete document to evaluate those statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Exchange Act. Our Exchange Act
number for our SEC filings is <FONT STYLE="white-space:nowrap">0-22818.</FONT> We file information electronically with the SEC. Our SEC filings are available from the SEC&#146;s internet site at http://www.sec.gov, which contains reports, proxy and
information statements and other information regarding issuers that file electronically. Our internet address is http://www.hain.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
also make our annual, quarterly and current reports, proxy statements and other information available free of charge through the investor relations section of our website, https://ir.hain.com/, as soon as reasonably practicable after we
electronically file these materials with, or furnish them to, the SEC. The information on or accessible through our website that is not specifically incorporated by reference herein is not a part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc253634_12"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus supplement and the accompanying prospectus, which
means that we can disclose important information to you by referring to those documents. We hereby &#147;incorporate by reference&#148; the documents listed below, which means that we are disclosing important information to you by referring you to
those documents. The information that we file later with the SEC will automatically update and in some cases supersede this information. Specifically, we incorporate by reference the following documents or information filed with the SEC (other than,
in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000033/hain-20210630.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended June&nbsp;30, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000057/hain-20210930.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended September&nbsp;30, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000039/hain-20211028.htm">Form
 <FONT STYLE="white-space:nowrap">8-K</FONT></A> filed on November&nbsp;1, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our capital stock contained in the Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A/A</FONT> dated November&nbsp;
12, 1993 and any amendment or report filed for the purpose of updating such description, including the description of our securities contained in <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000091040619000077/hain-63019xex42.htm">Exhibit 4.2
</A> of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;
30, 2021, which incorporated by reference to <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000091040619000077/hain-63019xex42.htm">Exhibit 4.2</A> of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year
ended June&nbsp;30, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000119312521276224/d159750ddef14a.htm">definitive proxy statement
</A> filed on September&nbsp;17, 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date
of this prospectus supplement and before the termination of this offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information
incorporated by reference or provided in this prospectus supplement and the accompanying prospectus. We have not authorized anyone else to provide you with other information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide, without charge, to each person to whom a copy of this prospectus supplement and the accompanying prospectus has been
delivered, including any beneficial owner, a copy of any and all of the documents referred to herein that are summarized in this prospectus supplement and the accompanying prospectus, if such person makes a written request directed to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Hain Celestial Group, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1111 Marcus Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lake Success,
NY 11042 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(516) <FONT STYLE="white-space:nowrap">587-5000</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">investorrelations@hain.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Hain Celestial Group, Inc., our logos and all of our other product and service names are registered trademarks or trademarks of The Hain Celestial Group, Inc. in the USA and other select countries.
&#147;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&#148; and &#147;<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>&#148; indicate USA registration and USA trademark, respectively. Other third party logos and product/trade
names are registered trademarks or tradenames of their respective companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g621396g01a02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>THE HAIN CELESTIAL GROUP, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>DEBT SECURITIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>PREFERRED STOCK </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>COMMON
STOCK </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>DEPOSITARY SHARES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>WARRANTS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>STOCK PURCHASE
CONTRACTS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>STOCK PURCHASE UNITS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, or any
selling security holder, may from time to time offer to sell the securities covered by this prospectus. Our common stock is listed on the Nasdaq Global Select Market and trades under the ticker symbol &#147;HAIN.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, or any selling security holder, may offer and sell these securities to or through one or more underwriters, dealers and agents, or
directly to purchasers, on a continuous or delayed basis. When we, or any selling security holder, offer and sell these securities, we will provide specific terms of any securities to be offered in supplements to this prospectus. You should read
this prospectus and the applicable prospectus supplement carefully before you invest. The shares of our common stock may be sold at fixed prices, prevailing market prices at the time of sale, prices related to the prevailing market prices, varying
prices determined at the times of sale or negotiated prices. The shares of our common stock offered by this prospectus may be offered by us or any selling security holder directly to investors or to or through underwriters, dealers or agents
involved in the offering and any applicable fees, commission or discount arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at
1111 Marcus Avenue, Lake Success, NY 11042. Our telephone number is <FONT STYLE="white-space:nowrap">(516)&nbsp;587-5000.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><B>Investing in
any of our securities involves risks. You should carefully read and consider the matters described under the caption &#147;<A HREF="#rom621396_3">Risk Factors</A>&#148; on page&nbsp;3 of this prospectus and set forth in the documents incorporated by
reference herein before you invest in our securities. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is November&nbsp;10, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_2">THE HAIN CELESTIAL GROUP, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_4">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_6">SELLING SECURITY HOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_7">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_8">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_9">DESCRIPTION OF PREFERRED STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_10">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_11">DESCRIPTION OF OTHER SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_14">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom621396_15">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of an automatic shelf registration statement that we filed with the Securities and Exchange Commission (the
&#147;SEC&#148;) as a &#147;well-known seasoned issuer&#148; as defined in Rule 405 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), utilizing a &#147;shelf&#148; registration process. Under this process, we or selling
security holders may from time to time sell the securities described in this prospectus in one or more offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
provides you with a general description of the securities that we or selling security holders may offer. Each time we or selling security holders sell securities, we will provide you with a prospectus supplement containing specific information about
the terms of the offering. The prospectus supplement may also add, update or change information contained in this prospectus and may include other special considerations applicable to such offering of securities. If there is any inconsistency
between the information in this prospectus and any prospectus supplement, you should rely on the information in the prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement will describe: the terms of the securities offered, any initial public offering price, the price paid to us or the
selling security holders for the securities, the net proceeds to us or the selling security holders, the manner of distribution and any underwriting compensation and the other specific material terms related to the offering of the applicable
securities. For more detail on the terms of the securities, you should read the exhibits filed with or incorporated by reference in our registration statement of which this prospectus forms a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read carefully this prospectus and any prospectus supplement together with the additional information described under the heading
&#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Documents by Reference.&#148; You should rely only on the information contained or incorporated by reference in this prospectus, any accompanying prospectus
supplement and any applicable &#147;free writing prospectus.&#148; We have not authorized, and no selling security holder has authorized, anyone else to provide you with different or additional information. No offer of securities is being made in
any jurisdiction where the offer or sale is not permitted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not assume that the information in this prospectus, any
accompanying prospectus supplement, or any document incorporated by reference herein or therein is accurate as of any date other than their respective dates. Our business, financial condition, results of operations, and prospects may have changed
since those dates. You should carefully read the entire prospectus, as well as the documents incorporated by reference in the prospectus, any applicable prospectus supplement and any applicable &#147;free writing prospectus&#148; before making an
investment decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in this prospectus to &#147;securities&#148; include any security that we or selling security holders
might sell under this prospectus or any prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in this prospectus to &#147;the Company,&#148; &#147;we,&#148;
&#147;our&#148; and &#147;us&#148; or other similar terms mean The Hain Celestial Group, Inc. and its wholly owned subsidiaries, unless we state otherwise or the context indicates otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_2"></A>THE HAIN CELESTIAL GROUP, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Founded in 1993, we are a Delaware corporation and are headquartered in Lake Success, New York. Our mission has continued to evolve since our
founding, with health and wellness being the core tenet. We continue to be a leading marketer, manufacturer and seller of organic and natural, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;better-for-you&#148;</FONT></FONT>
products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. We are committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing
processes. We sell our products through specialty and natural food distributors, supermarkets, natural food stores, mass market and <FONT STYLE="white-space:nowrap">e-commerce</FONT> retailers, food service channels and club, drug and convenience
stores in over 80 countries worldwide. We operate under two reportable segments: North America and International. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We manufacture, market,
distribute and sell organic and natural products under brand names that are sold as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;better-for-you&#148;</FONT></FONT> products, providing consumers with the opportunity to lead
A Healthier Way of Life<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. We are a leader in many organic and natural products categories, with many recognized brands in the various market categories we serve, including Celestial Seasonings<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Clarks<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, Cully&nbsp;&amp; Sully<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Earth&#146;s Best<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Ella&#146;s Kitchen<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Frank Cooper&#146;s<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Gale&#146;s<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Garden of Eatin&#146;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hain Pure Foods<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Hartley&#146;s<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Health Valley<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Imagine<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,
Joya<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Lima<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Linda McCartney&#146;s<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;(under license), MaraNatha<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Natumi<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, New Covent Garden Soup Co.<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Robertson&#146;s<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Rose&#146;s<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>(under license), Sensible Portions<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Spectrum<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, <FONT STYLE="white-space:nowrap">Sun-Pat</FONT><SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Terra<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, The Greek Gods<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Yorkshire Provender<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Yves Veggie Cuisine<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. Our personal care products are marketed under the Alba Botanica<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Avalon
Organics<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, JASON<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Live Clean<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, and Queen Helene<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;brands. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 1111 Marcus Avenue,
Lake Success, NY 11042. Our telephone number is <FONT STYLE="white-space:nowrap">(516)&nbsp;587-5000.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investment in any securities offered pursuant to this prospectus and any applicable prospectus supplement involves risks. Prior to making a
decision about investing in our securities, you should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended June&nbsp;30, 2021 and any
subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and all other information contained or incorporated by reference in this prospectus, as updated
by our subsequent filings under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and the risk factors and other information contained or incorporated by reference in the applicable prospectus supplement. See
&#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Information by Reference&#148; in this prospectus. Our business, prospects, financial condition or operating results could be materially adversely affected by any of
these risks, as well as other risks not currently known to us or that we currently consider immaterial. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment. See also
&#147;Forward-Looking Statements&#148; in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_4"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and the information incorporated or deemed to be incorporated by reference in this prospectus and
any prospectus supplement may include forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, and Section&nbsp;21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. We make such
forward-looking statements pursuant to the &#147;safe harbor&#148; provisions of the Private Securities Litigation Reform Act of 1995. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All statements included or incorporated or deemed to be incorporated by reference into this prospectus and any prospectus supplement, other
than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Such statements involve risks, uncertainties
and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words &#147;believe,&#148;
&#147;expect,&#148; &#147;anticipate,&#148; &#147;may,&#148; &#147;should,&#148; &#147;plan,&#148; &#147;intend,&#148; &#147;potential,&#148; &#147;will&#148; and similar expressions are intended to identify such forward-looking statements.
Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives, business strategy, supply chain, brand portfolio and
product performance; the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; current or future macroeconomic trends; and future corporate acquisitions or dispositions. We undertake no obligation to further update forward-looking statements,
or the risk factors described &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2021, to reflect actual results or changes in assumptions or circumstances,
except as required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements included or incorporated or deemed to be incorporated by reference
into this prospectus and any prospectus supplement do not constitute guarantees or promises of future performance. Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and
uncertainty resulting from the impact of competition; challenges and uncertainty resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; our ability to manage our supply chain effectively; disruption of operations at our
manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences; customer concentration; reliance on independent distributors; the availability of organic ingredients; risks associated with our international
sales and operations; risks associated with outsourcing arrangements; our ability to execute our cost reduction initiatives and related strategic initiatives; our reliance on independent certification for a number of our products; the reputation of
our Company and our brands; our ability to use and protect trademarks; general economic conditions; input cost inflation; the United Kingdom&#146;s exit from the European Union; cybersecurity incidents; disruptions to information technology systems;
the impact of climate change; liabilities, claims or regulatory change with respect to environmental matters; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; pending and
future litigation; compliance with data privacy laws; compliance with our credit agreement; the discontinuation of LIBOR; concentration in the ownership of our common stock; our ability to issue preferred stock; the adequacy of our insurance
coverage; impairments in the carrying value of goodwill or other intangible assets; and other risks described under &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
June&nbsp;30, 2021 as well as in other reports that we file in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cautioned not to rely unduly on any forward-looking
statements. The risks and uncertainties related to any forward-looking statements are discussed in more detail under the &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; sections of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2021 and our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended
September&nbsp;30, 2021 and other documents on file with the SEC. You may obtain copies of these documents as described under &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Information by Reference&#148; in this
prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in a prospectus supplement, we intend to use the net proceeds from the sale of our securities for general corporate
purposes. Unless otherwise indicated in a prospectus supplement, we will not receive the net proceeds of any sales by selling security holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_6"></A>SELLING SECURITY HOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will set forth information about selling security holders, where applicable, in a prospectus supplement, in a post-effective amendment, or
in filings we make with the SEC under the Exchange Act that are incorporated by reference. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_7"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or selling security holders may offer and sell the securities covered by this prospectus from time to time, in one or more transactions, at
market prices prevailing at the time of sale, at prices related to market prices, at a fixed price or prices subject to change, at varying prices determined at the time of sale or at negotiated prices, by a variety of methods, including the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in &#147;at the market offerings,&#148; within the meaning of Rule 415(a)(4) under the Securities Act, to or
through a market maker or into an existing trading market, on an exchange or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through brokers or dealers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly by us or selling security holders to purchasers, including through a specific bidding, auction or other
process; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through a combination of any of these methods of sale. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Registration of the securities covered by this prospectus does not mean that those securities necessarily will be offered or sold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In effecting sales, brokers or dealers engaged by us may arrange for other brokers or dealers to participate. Broker-dealer transactions may
include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases of the securities by a broker-dealer as principal and resales of the securities by the broker-dealer
for its account pursuant to this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transactions in which the broker-dealer solicits purchasers; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities covered by this prospectus may be sold: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a national securities exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions other than on an exchange or in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or in combination. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we or selling
security holders may sell any securities covered by this prospectus in private transactions or pursuant to other exemptions from registration under the Securities Act rather than pursuant to this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or selling security holders may sell offered securities through agents designated by us or selling security holders from time to time. Any
such agent in the offer or sale of the securities for which this prospectus is delivered will be named, and any commissions payable by us or selling security holders to that agent will be set forth, in the prospectus supplement to the extent
required. Unless indicated in the prospectus supplement, such agents will have agreed to use their reasonable best efforts to solicit purchases for the period of their appointment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of securities covered by this prospectus, broker-dealers may receive compensation from us or selling security
holders in the form of commissions, discounts or concessions. Broker-dealers may also receive compensation from purchasers of the securities for whom they act as agents or to whom </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
they sell as principals or both. Compensation as to a particular broker-dealer may be in excess of customary commissions or in amounts to be negotiated. In connection with any underwritten
offering, underwriters may receive compensation in the form of discounts, concessions or commissions from us, selling security holders or from purchasers of the securities for whom they act as agents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters may sell the securities to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or
commissions from the underwriters and/or compensation from the purchasers for whom they may act as agents. Any underwriters, broker-dealers, agents or other persons acting on our behalf who participate in the distribution of the securities may be
deemed to be &#147;underwriters&#148; within the meaning of the Securities Act, and any profit on the sale of the securities by them and any discounts, commissions or concessions received by any of those underwriters, broker-dealers, agents or other
persons may be deemed to be underwriting discounts and commissions under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the distribution of the
securities covered by this prospectus or otherwise, we may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short
sales of our securities in the course of hedging the positions they assume with us. We may also sell securities short and deliver the securities offered by this prospectus to close out our short positions. We may also enter into option or other
transactions with broker-dealers or other financial institutions, which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial
institution may resell pursuant to this prospectus, as supplemented or amended to reflect such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time a particular
offer of the securities covered by this prospectus is made, a revised prospectus or prospectus supplement, if required, will be distributed that will set forth the aggregate amount of securities covered by this prospectus being offered and the terms
of the offering. Such prospectus supplement, and, if necessary, a post-effective amendment to the registration statement of which this prospectus is a part, will be filed with the SEC to reflect the disclosure of additional information with respect
to the distribution of the securities covered by this prospectus. In order to comply with the securities laws of certain states, if applicable, the securities sold under this prospectus may only be sold through registered or licensed broker-dealers.
In addition, in some states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from registration or qualification requirements is available and is complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with an underwritten offering, we would execute an underwriting agreement with an underwriter or underwriters. Unless otherwise
indicated in the revised prospectus or applicable prospectus supplement, such underwriting agreement would provide that the obligations of the underwriter or underwriters are subject to certain conditions precedent, and that the underwriter or
underwriters with respect to a sale of the covered securities will be obligated to purchase all of the covered securities, if any such securities are purchased. We may grant to the underwriter or underwriters an option to purchase additional
securities at the public offering price, less any underwriting discount, as may be set forth in the revised prospectus or applicable prospectus supplement. If we grant any such option, the terms of that option will be set forth in the revised
prospectus or applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, agents, brokers or dealers may be entitled, pursuant to relevant agreements
entered into with us, to indemnification by us against certain civil liabilities, including liabilities under the Securities Act that may arise from any untrue statement or alleged untrue statement of a material fact, or any omission or alleged
omission to state a material fact in this prospectus, any supplement or amendment hereto, or in the registration statement of which this prospectus forms a part, or to contribution with respect to payments which the underwriters, agents, brokers or
dealers may be required to make. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters or agents and their affiliates may be customers of, engage in transactions with or perform
services for us or our affiliates from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_8"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description of the terms of the debt securities sets forth certain general terms and provisions of the debt securities to
which any prospectus supplement may relate. The particular terms of the debt securities offered by any prospectus supplement and the extent, if any, to which these general provisions may apply to those debt securities will be described in the
prospectus supplement relating to those debt securities. Accordingly, for a description of the terms of a particular issue of debt securities, reference must be made to both the prospectus supplement relating thereto and to the following
description. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue debt securities from time to time in one or more series. The debt securities will be general obligations of
The Hain Celestial Group, Inc. The debt securities may be fully and unconditionally guaranteed on a secured or unsecured senior or subordinated basis, jointly and severally, by guarantors, if any. In the event that any series of debt securities will
be subordinated to other indebtedness that we have outstanding or may incur, the terms of the subordination will be set forth in the prospectus supplement relating to the subordinated debt securities. Debt securities may be issued under a document
called the indenture. Each indenture is a contract between us and a trustee to be named therein. The debt indentures and their associated documents, including the debt security, will contain the full legal text of the matters described in this
section and the applicable prospectus supplement. We have filed a form of the indenture with the SEC as an exhibit to our registration statement of which this prospectus is a part. The following discussion of certain provisions of the indenture is a
summary only and should not be considered a complete description of the terms and provisions of the indenture. Accordingly, the following discussion is qualified in its entirety by reference to the provisions of the indenture, including the
definition of certain terms used below. You should refer to the indenture for the complete terms of the debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities will represent direct, general obligations of The Hain Celestial Group, Inc. and: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may rank equally with other unsubordinated debt or may be subordinated to other debt we have or may incur;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may be issued in one or more series with the same or various maturities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may be issued at a price of 100% of their principal amount or at a premium or discount; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may be issued in registered or bearer form and certificated or uncertificated form; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may be represented by one or more global notes registered in the name of a designated depositary&#146;s nominee,
and if so, beneficial interests in the global note will be shown on and transfers will be made only through records maintained by the designated depositary and its participants. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate principal amount of debt securities that we may authenticate and deliver is unlimited. Subject to limitations contained in the
indenture, we may from time to time, without notice to or the consent of the holders of a series of debt securities, issue additional debt securities of any such series on the same terms and conditions as the debt securities of such series, except
for any differences in the issue price and, if applicable, the initial interest accrual date and interest payment date; provided that if the additional debt securities are not fungible with the debt securities of such series for U.S. federal income
tax purposes, such additional debt securities will have one or more separate CUSIP numbers. You should refer to the applicable prospectus supplement for the following terms of the debt securities of the series with respect to which that prospectus
supplement is being delivered: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the debt securities of the series (which will distinguish the debt securities of that particular
series from the debt securities of any other series); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices of the debt securities of the series; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the debt securities of the series that may be authenticated and
delivered under the indenture (except for debt securities authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of, other debt securities of the series); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which the principal and any premium with respect to the debt securities of the series are
payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates (which may be fixed or variable) at which the debt securities of the series will bear interest
(if any) or the method of determining such rate or rates, the date or dates from which such interest, if any, will accrue, the interest payment dates on which such interest, if any, will be payable or the method by which such dates will be
determined, the record dates for the determination of holders thereof to whom such interest is payable (in the case of securities in registered form), and the basis upon which interest will be calculated if other than that of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the person to whom any interest on a debt security of the series shall be payable if other than the person in
whose name that security is registered at the close of business on the record date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currencies in which debt securities of the series will be denominated and/or in which payment of
the principal, premium, if any, and interest of any of the securities shall be payable, if other than U.S. dollars, the place or places, if any, in addition to or instead of the corporate trust office of the trustee (in the case of securities in
registered form) where the principal, premium and interest with respect to debt securities of the series will be payable or the method of such payment, if by wire transfer, mail or other means; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices at which, the period or periods within which, and the terms and conditions upon which debt
securities of the series may be redeemed, in whole or in part, at our option or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether debt securities of the series are to be issued as securities in registered form or securities in bearer
form or both and, if securities in bearer form are to be issued, whether coupons will be attached to them, whether securities in bearer form of the series may be exchanged for securities in registered form of the series, and the circumstances under
which and the places at which any such exchanges, if permitted, may be made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any debt securities of the series are to be issued as securities in bearer form or as one or more global
securities representing individual securities in bearer form of the series, whether certain provisions for the payment of additional interest or tax redemptions will apply; whether interest with respect to any portion of a temporary bearer security
of the series payable with respect to any interest payment date prior to the exchange of such temporary bearer security for definitive securities in bearer form of the series will be paid to any clearing organization with respect to the portion of
such temporary bearer security held for its account and, in such event, the terms and conditions (including any certification requirements) upon which any such interest payment received by a clearing organization will be credited to the persons
entitled to interest payable on such interest payment date; and the terms upon which a temporary bearer security may be exchanged for one or more definitive securities in bearer form of the series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the obligation or right, if any, to redeem, purchase or repay debt securities of the series pursuant to any
sinking fund or analogous provisions or at the option of a holder of such debt securities and the price or prices at which, the period or periods within which, and the terms and conditions upon which, debt securities of the series will be redeemed,
purchased or repaid, in whole or in part, pursuant to such obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, upon which the debt securities of the series may be convertible into or exchanged for any
issuer&#146;s common stock, preferred stock, depositary shares, other debt securities or warrants for common stock, preferred stock, depositary shares, indebtedness or other securities of any kind and the terms and conditions upon which such
conversion or exchange will be effected, including the initial conversion or exchange price or rate, the conversion or exchange period and any other additional provisions; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than minimum denominations of $2,000 or any integral multiple of $1,000 in excess thereof, the
denominations in which debt securities of the series will be issuable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the amount of principal, premium or interest with respect to the debt securities of the series may be
determined with reference to an index or pursuant to a formula, the manner in which such amounts will be determined; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the principal amount payable at the stated maturity of debt securities of the series will not be determinable
as of any one or more dates prior to such stated maturity, the amount that will be deemed to be such principal amount as of any such date for any purpose, including the principal amount thereof which will be due and payable upon any maturity other
than the stated maturity or which will be deemed to be outstanding as of any such date (or, in any such case, the manner in which such deemed principal amount is to be determined), and if necessary, the manner of determining the equivalent thereof
in U.S. dollars; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any changes or additions to the provisions of the indenture dealing with defeasance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than the principal amount thereof, the portion of the principal amount of debt securities of the series
that will be payable upon declaration of acceleration of the maturity thereof or provable in bankruptcy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, of the transfer, mortgage, pledge or assignment as security for the debt securities of the
series of any properties, assets, moneys, proceeds, securities or other collateral and any corresponding changes to provisions of the indenture as then in effect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to or change in the events of default with respect to the debt securities of the series and any
change in the right of the trustee or the holders to declare the principal, premium and interest, if any, with respect to such debt securities due and payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the debt securities of the series will be issued in whole or in part in the form of a global security, the
terms and conditions, if any, upon which such global security may be exchanged in whole or in part for other individual debt securities in definitive registered form, the depositary (as defined in the applicable prospectus supplement) for such
global security and the form of any legend or legends to be borne by any such global security in addition to or in lieu of the legend referred to in the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any trustee, authenticating or paying agent, transfer agent or registrar or any other agent with respect to the
debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the applicability of, and any addition to or change in, the covenants and definitions then set forth in the
indenture or in the terms then set forth in the indenture relating to permitted consolidations, mergers or sales of assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, of any guarantee of the payment of principal, premium and interest with respect to debt
securities of the series and any corresponding changes to the provisions of the indenture as then in effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the subordination, if any, of the debt securities of the series pursuant to the indenture and any changes or
additions to the provisions of the indenture relating to subordination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with regard to debt securities of the series that do not bear interest, the dates for certain required reports to
the trustee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions granting special rights to holders when a specified event occurs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any guarantor or <FONT STYLE="white-space:nowrap">co-issuer;</FONT> and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the debt securities of the series (which terms will not be prohibited by the provisions of the
indenture). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement will also describe any material U.S. federal income tax
consequences or other special considerations applicable to the series of debt securities to which such prospectus supplement relates, including those applicable to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">securities in bearer form; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">debt securities with respect to which payments of principal, premium or interest are determined with reference to
an index or formula (including changes in prices of particular securities, currencies or commodities); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">debt securities with respect to which principal or interest is payable in a foreign or composite currency;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">debt securities that are issued at a discount below their stated principal amount, bearing no interest or
interest at a rate that at the time of issuance is below market rates or original issue discount debt securities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variable rate debt securities that are exchangeable for fixed rate debt securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the applicable prospectus supplement, securities in registered form may be transferred or exchanged at the office
of the trustee at which its corporate trust business is principally administered in the United States, subject to the limitations provided in the indenture, without the payment of any service charge, other than any tax or governmental charge payable
in connection therewith. Securities in bearer form will be transferable only by delivery. Provisions with respect to the exchange of securities in bearer form will be described in the prospectus supplement relating to those securities in bearer
form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All funds that we pay to a paying agent for the payment of principal, premium or interest with respect to any debt securities that
remain unclaimed at the end of two years after that principal, premium or interest will have become due and payable will be repaid to us, and the holders of those debt securities or any related coupons will thereafter look only to us for payment
thereof. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt
securities of a series may be issued in whole or in part in the form of one or more global securities. A global security is a debt security that represents, and is denominated in an amount equal to the aggregate principal amount of, all outstanding
debt securities of a series, or any portion thereof, in either case having the same terms, including the same original issue date, date or dates on which principal and interest are due, and interest rate or method of determining interest. A global
security will be deposited with, or on behalf of, a depositary, which will be identified in the prospectus supplement relating to such debt securities. Global securities may be issued in either registered or bearer form and in either temporary or
definitive form. Unless and until it is exchanged in whole or in part for the individual debt securities represented thereby, a global security may not be transferred except as a whole by the depositary to a nominee of the depositary, by a nominee
of the depositary to the depositary or another nominee of the depositary, or by the depositary or any nominee of the depositary to a successor depositary or any nominee of such successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the depositary arrangement with respect to a series of debt securities will be described in the prospectus supplement relating to
such debt securities. We anticipate that the following provisions will generally apply to depositary arrangements, in all cases subject to any restrictions or limitations described in the prospectus supplement relating to such debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the issuance of a global security, the depositary for such global security will credit, on its book entry registration and transfer
system, the respective principal amounts of the individual debt securities represented by such global security to the accounts of persons that have accounts with the depositary. Such accounts will be designated by the dealers or underwriters with
respect to such debt securities or, if such debt securities are offered and sold directly by us or through one or more agents, by us or such agents. Ownership of beneficial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interests in a global security will be limited to participants or persons that hold beneficial interests through participants. Ownership of beneficial interests in such global security will be
shown on, and the transfer of that ownership will be effected only through, records maintained by the depositary (with respect to interests of participants) or records maintained by participants (with respect to interests of persons other than
participants). The laws of some states require that certain purchasers of securities take physical delivery of such securities in definitive form. Such limitations and laws may impair the ability to transfer beneficial interests in a global
security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as the depositary for a global security, or its nominee, is the registered owner or holder of such global security,
such depositary or nominee, as the case may be, will be considered the sole owner or holder of the individual debt securities represented by such global security for all purposes under the indenture. Except as provided below, owners of beneficial
interests in a global security will not be entitled to have any of the individual debt securities represented by such global security registered in their names, will not receive or be entitled to receive physical delivery of any of such debt
securities in definitive form and will not be considered the owners or holders thereof under the indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of principal,
premium, if any, and interest with respect to individual debt securities represented by a global security will be made to the depositary or its nominee, as the case may be, as the registered owner or holder of such global security. Neither we, the
trustee, any paying agent or registrar for such debt securities nor any agent of ours or the trustee will have any responsibility or liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any aspect of the records relating to or payments made by the depositary, its nominee or any participants on
account of beneficial interests in the global security or for maintaining, supervising or reviewing any records relating to such beneficial interests; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the payment to the owners of beneficial interests in the global security of amounts paid to the depositary or its
nominee; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other matter relating to the actions and practices of the depositary, its nominee or its participants.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we, the trustee, any paying agent or registrar for such debt securities nor any agent of ours or the trustee
will be liable for any delay by the depositary, its nominee or any of its participants in identifying the owners of beneficial interests in the global security, and we and the trustee may conclusively rely on, and will be protected in relying on,
instructions from the depositary or its nominee for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that the depositary for a series of debt securities or its
nominee, upon receipt of any payment of principal, premium or interest with respect to a definitive global security representing any of such debt securities, will immediately credit participants&#146; accounts with payments in amounts proportionate
to their respective beneficial interests in the principal amount of such global security, as shown on the records of the depositary or its nominee. We also expect that payments by participants to owners of beneficial interests in such global
security held through such participants will be governed by standing instructions and customary practices, as is now the case with securities held for the accounts of customers and registered in &#147;street name.&#148; Such payments will be the
responsibility of such participants. See &#147;&#151;Limitations on Issuance of Securities in Bearer Form&#148; below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the depositary
for a series of debt securities is at any time unwilling, unable or ineligible to continue as depositary, we will appoint a successor depositary. If a successor depositary is not appointed by us within 90 days, we will issue individual debt
securities of such series in exchange for the global security representing such series of debt securities. In addition, we may at any time and in our sole discretion determine to no longer have debt securities of a series represented by a global
security and, in such event, will issue individual debt securities of such series in exchange for the global security representing such series of debt securities. Furthermore, if we so specify with respect to the debt securities of a series, an
owner of a beneficial interest in a global security representing debt securities of such series may, on terms acceptable to us, the trustee and the depositary for such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
global security, receive individual debt securities of such series in exchange for such beneficial interests. In any such instance, an owner of a beneficial interest in a global security will be
entitled to physical delivery of individual debt securities of the series represented by such global security equal in principal amount to such beneficial interest and to have such debt securities registered in its name (if the debt securities are
issuable as securities in registered form). Individual debt securities of such series so issued generally will be issued: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as securities in registered form in minimum denominations, unless otherwise specified by us, of $2,000 and any
integral multiples of $1,000 in excess thereof if the debt securities are issuable as securities in registered form; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as securities in bearer form in the denomination or denominations specified by us if the debt securities are
issuable as securities in bearer form; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as either securities in registered form or securities in bearer form as described above if the debt securities
are issuable in either form. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Issuance of Securities in Bearer Form </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities of a series may be issued as securities in registered form (which will be registered as to principal and interest in the
register maintained by the registrar for such debt securities) or securities in bearer form (which will be transferable only by delivery). If such debt securities are issuable as securities in bearer form, the applicable prospectus supplement will
describe certain special limitations and considerations that will apply to such debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Covenants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If debt securities are issued, the indenture, as supplemented for a particular series of debt securities, will contain certain covenants for
the benefit of the holders of such series of debt securities, which will be applicable (unless waived or amended) so long as any of the debt securities of such series are outstanding, unless stated otherwise in the prospectus supplement. The
specific terms of the covenants, and summaries thereof, will be set forth in the prospectus supplement relating to such series of debt securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subordination </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt securities of a
series, and any guarantees, may be subordinated, which we refer to as subordinated debt securities, to senior indebtedness (as defined in the applicable prospectus supplement) to the extent set forth in the prospectus supplement relating thereto. To
the extent we conduct operations through subsidiaries, the holders of debt securities (whether or not subordinated debt securities) will be structurally subordinated to the creditors of our subsidiaries, except to the extent such subsidiary is a
guarantor of such series of debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the following will constitute an event of default under the indenture with respect to any series of debt securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay interest on the debt securities of that series within 30 days of the due date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in payment of the principal or premium, if any, on the debt securities of that series, when such amount
becomes due and payable at maturity, upon acceleration, required redemption or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to comply with the obligations described under &#147;&#151;Mergers and Sales of Assets&#148; below;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to comply for 60 days after notice with any of our other agreements in the debt securities of that series
or the indenture or supplemental indenture related to that series of debt securities; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events of bankruptcy, insolvency or reorganization affecting us. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A prospectus supplement may omit, modify or add to the foregoing events of default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An event of default under one series of debt securities does not necessarily constitute an event of default under any other series of debt
securities. A default under the fourth bullet above will not constitute an event of default until the trustee or the holders of 25% in principal amount of the outstanding debt securities of such series notify us of the default and we do not cure
such default within the time specified after receipt of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any event of default (other than an event of default relating to
certain events of bankruptcy, insolvency or reorganization) occurs and is continuing with respect to a particular series of debt securities, either the trustee or the holders of not less than 25% in aggregate principal amount of the debt securities
of that series then outstanding by written notice to us (and to the trustee if such notice is given by the holders), may declare the principal amount of (or in the case of original issue discount debt securities, the portion thereby specified in the
terms thereof), premium, if any, and accrued interest on the debt securities of that series to be immediately due and payable. In the case of certain events of bankruptcy, insolvency or reorganization, the principal amount of, premium, if any, and
accrued interest on the debt securities of that series will automatically become and be immediately due and payable without any declaration or other act on the part of the trustee or any holders. Upon a declaration by the trustee or the holders, we
will be obligated to pay the principal amount plus accrued and unpaid interest of each affected series of debt securities so declared due and payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of a majority in aggregate principal amount of the debt securities of any series then outstanding by notice to the trustee under
the indenture may on behalf of the holders of all of such series of debt securities waive any existing default or event of default and its consequences under the applicable indenture except a continuing default or event of default in the payment of
interest on, or the principal of, the debt securities of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of the indenture relating to the duties
of the trustee in case an event of default will occur and be continuing, the trustee is under no obligation to exercise any of its rights or powers under the indenture or debt securities at the request or direction of any of the holders of any
series of debt securities, unless such holders have offered to the trustee indemnity or security satisfactory to the trustee against any loss, liability or expense. Subject to such provisions for the indemnification of the trustee, the holders of at
least a majority in aggregate principal amount of the outstanding debt securities of a series have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power
conferred on the trustee with respect to such series of debt securities. The trustee, however, may refuse to follow any direction that conflicts with law or the indenture or that the trustee determines is unduly prejudicial to the rights of any
other holder of such series of debt securities or that would involve the trustee in personal liability. Prior to taking any action under the indenture, the trustee is entitled to indemnification satisfactory to it in its sole discretion against all
losses, liabilities and expenses caused by taking or not taking such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except to enforce the right to receive payment of principal,
premium, if any, or interest when due, no holder of debt securities of a series has any right to institute any proceeding with respect to the indenture or debt securities, or for the appointment of a receiver or a trustee, or for any other remedy
thereunder, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such holder has previously given to the trustee written notice of a continuing event of default with respect to
such series of debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder or holders of at least 25% in aggregate principal amount of the outstanding debt securities of that
series have made written request, and such holder or holders have offered security or indemnity satisfactory to the trustee against any loss, liability or expense, to the trustee to institute such proceeding as trustee; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustee has failed to institute such proceeding, and has not received from the holders of a majority in
aggregate principal amount of the outstanding debt securities of that series a direction inconsistent with such request, within 60 days after such notice, request and offer. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, such limitations do not apply to a suit instituted by a holder of a debt security
of such series for the enforcement of payment of the principal, premium, if any, or interest on such debt security on or after the applicable due date specified in such debt security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that if a default with respect to a series of debt securities occurs and is continuing and is known to the trustee, the
trustee must send to each holder of such debt securities notice of the default within 90 days after it occurs. Except in the case of a default in the payment of the principal or premium, if any, upon acceleration, redemption or otherwise with
respect to any debt security of a series when such amount becomes due and payable, the trustee may withhold notice if and so long as a committee of its trust officers in good faith determines that withholding notice is in the interests of the
holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture requires us to furnish to the trustee, within 120 days after the end of each fiscal year, a statement by certain
of our officers as to whether or not we, to their knowledge, are in default in the performance or observance of any of the terms, provisions and conditions of the indenture and, if so, specifying all such known defaults. We are also required to
deliver to the trustee, within 30 days after the occurrence thereof, written notice of any event which would constitute a default; provided, however, that failure to provide such written notice will not in and of itself result in a default under the
indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Street name and other indirect holders should consult their banks and brokers for information on their requirements for giving
notice or taking other actions upon a default. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions, modifications and amendments of the indenture, any supplemental indenture and any series of debt securities may
be made by us and the trustee with the consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of any series affected by such modification or amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No such modification or amendment may, without the consent of each holder affected thereby: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change to the percentage of principal amount of debt securities of any series the holders of which must
consent to an amendment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal amount of, premium, if any, or interest on, or extend the stated maturity or interest
payment periods of, any debt security (including the impairment of the right of any holder of any debt security to receive payment of principal of and interest on such holder&#146;s debt security); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any debt security payable in money or securities other than that stated in such debt security;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change that adversely affects such holder&#146;s right to require us to purchase a debt security, if
any; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right to institute suit for the enforcement of any payment with respect to the debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of any subordinated debt security or coupons pertaining thereto, make any change in the provisions of
the indenture relating to subordination that adversely affects the rights of any holder under such provisions (including any contractual subordination of senior unsubordinated debt securities); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the provisions applicable to the redemption of any debt security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except as provided under &#147;&#151;Satisfaction, Discharge and Defeasance,&#148; release any security or
guarantee that may have been granted with respect to the debt securities; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a default in payment of principal of, premium, if any, or interest on the debt securities of a series or
modify any provisions of the indenture relating to modification or amendment thereof. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without the consent of any holder, we and the trustee may amend the indenture for one or
more of the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to evidence the succession of another person pursuant to the provisions of the indenture relating to
consolidations, mergers and sales of assets and the assumption by such successor of the covenants, agreements and obligations in the indenture and in the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to surrender any right or power conferred upon us by the indenture, to add to our covenants such further
covenants, restrictions, conditions or provisions for the protection of the holders of all or any series of debt securities as our board of directors will consider to be for the protection of the holders of such debt securities, and to make the
occurrence, or the occurrence and continuance, of a default in respect of any of such additional covenants, restrictions, conditions or provisions a default or an event of default under the indenture (provided, however, that with respect to any such
additional covenant, restriction, condition or provision, such supplemental indenture may provide for a period of grace after default, which may be shorter or longer than that allowed in the case of other defaults, may provide for an immediate
enforcement upon such default, may limit the remedies available to the trustee upon such default or may limit the right of holders of a majority in aggregate principal amount of any series of debt securities to waive such default);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to cure any ambiguity or correct or supplement any provision contained in the indenture, in any supplemental
indenture or in any debt securities that may be defective or inconsistent with any other provision contained therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to conform any provision in the indenture to the &#147;Description of Notes&#148; included in the applicable
prospectus supplement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to convey, transfer, assign, mortgage or pledge any property to or with the trustee, or to make such other
provisions in regard to matters or questions arising under the indenture as will not adversely affect, in any material respect, the interests of any holders of debt securities of any series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to modify or amend the indenture in such a manner as to permit the qualification of the indenture or any
supplemental indenture under the Trust Indenture Act of 1939, as amended (the &#147;Trust Indenture Act&#148;), as then in effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add to or change any of the provisions of the indenture to provide that securities in bearer form may be
registerable as to principal; to change or eliminate any restrictions on the payment of principal or premium with respect to securities in registered form or of principal, premium or interest with respect to securities in bearer form; or to permit
securities in registered form to be exchanged for securities in bearer form, so as to not adversely affect the interests of the holders of debt securities or any coupons of any series in any material respect or permit or facilitate the issuance of
debt securities of any series in uncertificated form; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of subordinated debt securities, to make any change in the provisions of the indenture relating to
subordination that would limit or terminate the benefits available to any holder of senior indebtedness under such provisions (but only if each such holder of senior indebtedness consents to such change); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add guarantees with respect to the debt securities or to secure the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to make any change that does not adversely affect the rights of any holder in any material respect;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add to, change or eliminate any of the provisions of the indenture with respect to one or more series of debt
securities, so long as any such addition, change or elimination not otherwise permitted under the indenture will (a)&nbsp;neither apply to any debt security of any series created prior to the execution of such supplemental indenture and entitled to
the benefit of such provision nor modify the rights of the holders of any such debt security with respect to such provision or (b)&nbsp;become effective only when there is no such debt security outstanding; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to evidence and provide for the acceptance of appointment by a successor or separate trustee with respect to the
debt securities of one or more series and to add to or change any of the provisions of the indenture as will be necessary to provide for or facilitate the administration of the indenture by more than one trustee; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to establish the form or terms of debt securities and coupons of any series, as described under
&#147;&#151;General&#148; above. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mergers and Sales of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that we will not consolidate with or merge with or into, or convey, transfer or lease in one transaction or a series of
related transactions, directly or indirectly, all or substantially all of our properties and assets to, another person, unless (i)&nbsp;the resulting, surviving or transferee person, if not The Hain Celestial Group, Inc., is a person organized and
existing under the laws of the United States of America, any state thereof or the District of Columbia; (ii)&nbsp;immediately after giving effect to such transaction, no default or event of default has occurred and is continuing under the indenture;
(iii)&nbsp;the resulting, surviving or transferee person, if not The Hain Celestial Group, Inc., expressly assumes by supplemental indenture in a form satisfactory to the trustee all of our obligations under the debt securities and the indenture;
and (iv)&nbsp;we or the successor person has delivered to the trustee the certificates and opinions of counsel required under the indenture. Upon any such consolidation, merger or transfer, the resulting, surviving or transferee person shall succeed
to, and may exercise every right and power of, The Hain Celestial Group, Inc. under the indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Satisfaction, Discharge and Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided for in the prospectus supplement, the indenture will generally cease to be of any further effect with respect to a
series of debt securities if (a)&nbsp;we have delivered to the trustee for cancellation all outstanding debt securities of such series (with certain limited exceptions) or (b)&nbsp;all debt securities of such series have become due and payable or
will become due and payable at their maturity within one year or are to be called for redemption within one year, and we have deposited with the trustee, in trust, funds which will provide an amount sufficient to pay the entire indebtedness on such
debt securities of such series, including the principal thereof and premium, if any, and interest, if any, thereon (and if, in either case, we have also paid all other sums payable under the indenture with respect to such debt securities of such
series (including amounts payable to the trustee)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we will have a &#147;defeasance option&#148; (pursuant to which we may
terminate, with respect to the debt securities of a particular series, all of our obligations (with certain limited exceptions) under such debt securities and the indenture with respect to such debt securities) and a &#147;covenant defeasance
option&#148; (pursuant to which we may terminate, with respect to the debt securities of a particular series, our obligations with respect to such debt securities under certain specified covenants contained in the indenture). If we exercise our
defeasance option with respect to a series of debt securities, payment of such debt securities may not be accelerated because of an event of default. If we exercise our covenant defeasance option with respect to a series of debt securities, payment
of such debt securities may not be accelerated because of an event of default related to the specified covenants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable
prospectus supplement will describe the procedures we must follow in order to exercise our defeasance options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regarding the Trustee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that, except during the continuance of an event of default, the trustee will perform only such duties as are
specifically set forth in the indenture. During the existence of an event of default, the trustee may exercise such rights and powers vested in it under the indenture and use the same degree of care and skill in its exercise as a prudent person
would exercise under the circumstances in the conduct of such person&#146;s own affairs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture and provisions of the Trust Indenture Act that are incorporated by reference
therein contain limitations on the rights of the trustee, should it become one of our creditors, to obtain payment of claims in certain cases or to realize on certain property received by it in respect of any such claim as security or otherwise. The
trustee will be permitted to engage in other transactions with us or any of our affiliates; <I>provided</I>, <I>however</I>, that if it acquires any conflicting interest (as defined in the indenture or in the Trust Indenture Act), it must eliminate
such conflict or resign. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture and the debt securities will be governed by the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_9"></A>DESCRIPTION OF PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description of the terms of the preferred stock we may issue sets forth certain general terms and provisions of any series of
preferred stock to which any prospectus supplement may relate. Particular terms of the preferred stock offered by any prospectus supplement and the extent, if any, to which these general terms and provisions will apply to any series of preferred
stock so offered will be described in the prospectus supplement relating to the applicable preferred stock. The applicable prospectus supplement may also state that any of the terms set forth in this description are inapplicable to such series of
preferred stock. This description does not purport to be complete and is subject to and qualified in its entirety by reference to applicable Delaware law and the provisions of the Restated Certificate of Incorporation of The Hain Celestial Group,
Inc. (&#147;Certificate of Incorporation&#148;) relating to our preferred stock. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have 5,000,000 shares of preferred stock
authorized for issuance in one or more series, at a par value of $0.01 per share. As of September&nbsp;30, 2021, no shares of preferred stock were outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our certificate of incorporation, as amended, our board of directors has the authority to provide for the issuance of preferred
stock and in connection therewith to fix by resolution providing for the issue of such series, the number of shares to be included and such of the preferences and relative participating, optional or other special rights and limitations of such
series, including, without limitation, rights of redemption or conversion into common stock, to the fullest extent permitted by the Delaware General Corporation Law. The issuance of preferred stock could have the effect of decreasing the market
price of our common stock and could adversely affect the voting and other rights of the holders of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of each series
of preferred stock will be described in any prospectus supplement related to such series of preferred stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_10"></A>DESCRIPTION OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description of the terms of our common stock does not purport to be complete and is subject to and qualified in its entirety
by reference to applicable Delaware law and the provisions of our Certificate of Incorporation relating to our common stock. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
150,000,000 shares of common stock authorized for issuance, at a par value of $0.01 per share. As of November&nbsp;2, 2021, there were 94,581,455 shares of common stock outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of common stock entitles the holder to one vote on each matter voted on by stockholders. Under Article II, Section&nbsp;8 of the
Amended and Restated <FONT STYLE="white-space:nowrap">By-laws</FONT> of The Hain Celestial Group, Inc. <FONT STYLE="white-space:nowrap">(&#147;By-laws&#148;),</FONT> unless otherwise required by statute, our Certificate of Incorporation or our <FONT
STYLE="white-space:nowrap">By-laws,</FONT> any corporate action to be taken by vote of the stockholders shall be authorized by a majority of the votes cast by the holders of shares present in person or represented by proxy and entitled to vote on
such action at a meeting of stockholders at which a quorum is present. With respect to the election of directors, at each meeting of stockholders for the election of directors at which a quorum is present, the persons receiving a majority of the
votes cast at such election shall be elected, provided, however, that at any meeting of stockholders for which the Secretary of the Company determines that the number of nominees for director exceeds the number of directors to be elected, directors
shall be elected by a plurality of the votes of the shares represented in person or represented by proxy at such meeting and entitled to vote on the election of directors. There is no cumulative voting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any rights of holders of any then outstanding preferred stock, holders of common stock have the right to receive dividends when, as
and if declared by the Company&#146;s board of directors out of funds legally available for that purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any preferential
rights of holders of any then outstanding preferred stock, holders of common stock will share ratably in all assets legally available for distribution to our stockholders in the event of liquidation or dissolution of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock has no conversion rights, sinking fund provisions, redemption provisions or preemptive rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_11"></A>DESCRIPTION OF OTHER SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will set forth in the applicable prospectus supplement a description of any depository shares, warrants, stock purchase contracts or stock
purchase units that may be offered pursuant to this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the securities offered in this prospectus and any related prospectus supplement and certain legal matters will be passed upon
for us by Cravath, Swaine&nbsp;&amp; Moore LLP, New York, New York. If the securities are being distributed in an underwritten offering, certain legal matters will be passed upon for the underwriters by counsel identified in the related prospectus
supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_13"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of The Hain Celestial Group, Inc. and Subsidiaries (the &#147;Company&#148;) appearing in the
Company&#146;s Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended June&nbsp;30, 2021, and the effectiveness of the Company&#146;s internal control over financial reporting as of June&nbsp;30, 2021 have been audited
by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference
in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_14"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Exchange Act. Our Exchange Act
number for our SEC filings is <FONT STYLE="white-space:nowrap">0-22818.</FONT> We file information electronically with the SEC. Our SEC filings are available from the SEC&#146;s internet site at http://www.sec.gov, which contains reports, proxy and
information statements and other information regarding issuers that file electronically. Our internet address is http://www.hain.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
also make our annual, quarterly and current reports, proxy statements and other information available free of charge through the investor relations section of our website, www.hain-celestial.com, as soon as reasonably practicable after we
electronically file these materials with, or furnish them to, the SEC. The information on or accessible through our website that is not specifically incorporated by reference herein is not a part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom621396_15"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus, which means that we can disclose important
information to you by referring to those documents. We hereby &#147;incorporate by reference&#148; the documents listed below, which means that we are disclosing important information to you by referring you to those documents. The information that
we file later with the SEC will automatically update and in some cases supersede this information. Specifically, we incorporate by reference the following documents or information filed with the SEC (other than, in each case, documents or
information deemed to have been furnished and not filed in accordance with SEC rules): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000033/hain-20210630.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended June&nbsp;30, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000057/hain-20210930.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended September&nbsp;30, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000039/hain-20211028.htm">Form
 <FONT STYLE="white-space:nowrap">8-K</FONT></A> filed on November&nbsp;1, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our capital stock contained in the Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A/A</FONT> dated November&nbsp;
12, 1993 and any amendment or report filed for the purpose of updating such description, including the description of our securities contained in <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000091040619000077/hain-63019xex42.htm">Exhibit 4.2
</A> of our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/910406/000091040621000033/hain-20210630.htm">Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended
June&nbsp;
30, 2021, which incorporated by reference to <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000091040619000077/hain-63019xex42.htm">Exhibit 4.2</A> of our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000091040619000077/hain-06302019x10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended June&nbsp;30, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our <A HREF="http://www.sec.gov/Archives/edgar/data/910406/000119312521276224/d159750ddef14a.htm">definitive proxy statement
</A> filed on September&nbsp;17, 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, after the date
of this prospectus and before the termination of the offerings of all of the securities covered by this prospectus. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You
should rely only on the information incorporated by reference or provided in this prospectus and any prospectus supplement. We have not authorized anyone else to provide you with other information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide, without charge, to each person to whom a copy of this prospectus has been delivered, including any beneficial owner, a copy
of any and all of the documents referred to herein that are summarized in this prospectus, if such person makes a written request directed to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Hain Celestial Group, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1111 Marcus Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lake Success,
NY 11042 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(516) <FONT STYLE="white-space:nowrap">587-5000</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">investorrelations@hain.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Hain Celestial Group, Inc., our logos and all of our other product and service names are registered trademarks or trademarks of The Hain Celestial Group, Inc. in the USA and other select countries.
&#147;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&#148; and &#147;<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>&#148; indicate USA registration and USA trademark, respectively. Other third party logos and product/trade
names are registered trademarks or tradenames of their respective companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>12,379,504 Shares </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g253634g01a02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>The Hain Celestial Group, Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:50pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Morgan Stanley </B></P>
<P STYLE="margin-top:220pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>November 10, 2021 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g253634g01a02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g253634g01a02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C '0# 1$  A$! Q$!_\0
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MW$[4[3@ZJ7JG2(<[6K+!E$L#R [!2GH.WU.80D=YX(AT;+@Q"4LE!%L$1Y[
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MB;0R=N)B&8LI^^G7<%8$!*2R*;!Y@5S'Z7?!+2[6RMZT@-R>@YC1E]UHF*Z
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MJBIT&P&<O9)\OC8TG>1LA2BKVWB@BGD$^F:+F*[I_5"9N(XL1QX/U^N2J4?
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MQ^_EB  8_N9(RDA/QR8@?'6=TYO- C'^I?L?_67\_P"\:/\ >2/QTFWL9_\
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MQPUZJ*9@#L,X?>@K!D^WJ']1]OJ*T;<MI[ UKR+WI"6W<\D],[!E2(_1LO\
MEI9Z5EYM4@.%+:;,CXMU,E/2I"&8T48/&"O5D93+ [;4>WGY+L-6O9Q]"2&D
MH2N@-Y."!$3B2EU68<8U&V)/K>]D[ZZ/:\>-L7;53*Y*.?(.9+3E<:_-R\DG
M)5?'LB'G*YTBA?>M:  \'8_;.UYM34=;TM<=U[SD*A!7NR[1/)6;K5RQ6W8U
MJEK5)R5NLT^3K9\\D_#5PE8QD0%R/B<A)%<(CWSV,&YYUNY+-6W)=AIT5FD@
MCJJ.-GQQ5XDB588HQ:"A=PHQ9N3\MZ8*>/75;[0JW:,6/L9')/!'9FNNQ:F9
MI[4SS.\\TIIERW\]T"J43CQVA8<C+%IX>9MC>JBMD<D]QR]&T[=Z/<X>MSA.
MEJ91IB>H)P<M71+F="ZRJ[\V,E46C/XXJ;;QG"72PVV34)*;L<'2SF8:VN"[
M<BG>S%-6FN(MH15Q80K(!;N713KR%7) =PQ'X901T9*I1KBB<KG[@AI3U[,-
M1S119WJNK1>6*M12>= R@$ \0?N'%M,(5 JNN-%[!=TO1.4N^ZL]R*VO(.AZ
M^<HE3>9IELVY('R[\C0;'L?6T"Y%0)Y);IX+$ UL(5I&,S"FF7BR9<EQA[/^
MIM?0YV;%C-4\67AH8]+]F8K7JL:;Y>=7BH15WD$*&6">62=9%CB"J5>-7.<J
M4IVJXF_E!7R%YGE$R5/'6-N<O.] RUFE38=BB2*RJVI""W(M:$?BO2X+CJ+Q
M?UG/6O6= 17Y:J/E5=-:E[-*0ME8EVK2P89<ZU: E'64J;/D9&3%BQI!DYWY
M1;\>QC#&,P&0LSY,7Y(8[MMY8WCC*S<#+&4\(CC@DBD/ (J)&200-,K'I]_A
M%:'$C$UIIJ-189(7>,PM*T4JR"?F]B*9 93(SO(%5@QVA0>NN8X^\5J9P2UT
M;3V=U66"UQ*%RDC$L[KG=1U:/B9V5P+DZ8B9XVJTTHTC*!6? <I)2D4WC*E8
M QE7GILG[:[S[DD2X>UYX6(1?/+'+C8Y8U!XKRR=J*(I[)#Q\2?\\ZZI,:V!
M[9KR5(\ZSP%G<1RO5L&*5]<G5JM42<OM'V2%D'^9L]5/USJ[A[IW?.P>0$#W
M!@SME[#&EQMA%JO_ !ZLT)+"F& 2AF'1:QK8J-BFQ38R.,;?AWP,-I%2VZZX
M*\0T\P3=F=XW*$&/L8S 5Z]9E,"-EXR\;@,@'.')3\B0[ \BX.]_.B**M?[8
MQ^2M92'/9&2W<#+98UZK1R!V5C]GT$? !D0CAP(( .P6!L9I!K1E7K6PZI2>
M>58O4]LNQ2]T5.V#9/'3^MX>R60I]4W,5^*>J-? E,&OH9&9CYVO6*)BAXP.
M)AP  !OI=0LA^GG=LCP3)BL-8%:-(16HY>(>2*,?8K+8R$<A(&R?!(LKEBS%
MG.^K+'9[ P16H$SUUGN323FQ9@K&6*:4DR.GBI>,\CI0LL4D<:HJ1JB+KKD$
M<;==]G[3DWM[3.Y>15FB]T3=:J$[4G+%HXF"3/GP%FEHJ\P>9/1L\"S+5Y@&
M2:":9:_%2K!;+$RS(BA!,M;9;G'8N JY5S=EGO\ T5:U26:K''%;EJ2S221&
M6I8(-=HY4526Y@J)&?B#UCN=NU^VX9;4/FMPR7/IXUYQ1EE83/'+OP,N^$>R
MH10=_@ #J->UGH_3=HVKO;8W'/;O+C6-_EX<$G9\W;U<:;;&6!RX6.2F\(!%
M*TD:*$5^9C3C_8)&Q;6&\J80SEC_ &$=/8^1H9RUDI,8^7I3QQ1/;>PV.F20
MV)9&4(!5(#<HW;?!!K8 UZ$#MW+U\Q+;-:.U7>)8WF:4P.K&5GTJ\5/Y1B=J
MOKX_L9[$=N+6OY:ZV?8.T]P[BNE^MCMMG[CL4R@O2^2,P,#7!8B-%K%!K,%$
MUZ,C:Z"U%Q$=$#"@86^VPE+&6VFGQ,)#REDFLV;4LTGD>6<PEM\$C"J(X8T5
M%5!Q55 'O73,*J[8N\CLS<BS%1^ - *H   ] #IA_5UU)ZQ17,$CBIS5D\8:
M6AK3.^Q)X!II.4Y)KT';1;#$)0WG"<Y;D:[]3_;\?%;9.4_M*OWY%MHW;7=T
MF@=8G-K/& ".4$-I9XO7KU)!P]?!#:WH[ZP&PK8;/OZ/_(,D)5 ]%HHYA*GH
M_AXN/]A#?D=:Z-GN,F@5*YPQ#986<L/B'#J^;) QK;$G%%-.)_6674-K<;<Q
M^E8=1G'^<>=!_6>M)'%VQW32.S0N>+S)[_QOBO4) 1["*]:;3;URE0#1(WZT
M[+L13K?H,P:.Y76:/1VKH5:*77X/))8R/W"D_'QDYM_./87!7G#O_55HBG+_
M *(%W+:I>*K2923K-\HE0NTBJY0&=;WZ$(!L$4$) V*-6)7"S2Z^2&A34>Q"
M$G.R:'Z8Q3M]1#YS',JSPM7LS5'>&=1-'J:O)&X5XW4\2WC8D$CX89G+++2M
MSPR#:Q3R*ZG8>/BY_H(]^O?VDZ/XUO?6@?56UJSM36L%M_7]@*VMJ6RMYRRX
MH1I>TZCD=A"Y->,@MLDVEZ"><2B:J5F:-M9;"UF5RQR:DQ41*H.:[9Q&4KS2
M7Z8=7=XTR5*I%#G:4D:GG9EBJ1Q19JM"W 3U;$1R+1>1ZMBQ/XH^F_%=PY&B
M8VBLO9JGB37G<R(4) *HS<GB;7L%2 #HL&&U/76*<:@!81Z+: M4K<Y./A-<
M ,'Y;AK=)RT63.B2S\L/\EC4R*K09MNL4L,E97X0+$7%-$669@XXS.NU_P!/
M9[>>M099!+C,9+ "]>74&9>U']10CIVE^:=JJ/KIK,7*2.D-*JSRQZ>,OW/#
M7QD$]%U:S>4^!6T37"_;+)*AV T3;15;[6D!(YJI!5]SL[F$+PS+)UQK+,3M
M+E&2(VN>MEB&5B!U?'R(Z"1X]V  (0S%D);6R_!:ZA31HH8?+%LLLE+&39Z;
M=Z("_010U*<<->*#0@CKQ+##6BUZCBKJ0D;#9T29 ?\ &$RB697R2[D'\CL[
MM/:<EGDE8N=GWMR3L^M:4$:'SKT"KG@I-['W[RQ=YL\F=ERYU(U,3(V>QW">
M8!63/76/K_V:IK_7\9\0(8,B'?3&6.91#-PU=J%)A7';1(U:-F07B(-N"I'6
MOV[$T=&2W&\37C$9;,UR2LU>N(XHN,UZ>!=&"JA.DB2,>--,L7'R.;L-N?<L
M=:197!/%6\9#>)201&&(^Y@"$79/LC<T\J^\UL*P3!U$XOJ;U=2F\K%*NT;Z
MBMB6/&4JPI3-N,:QFNAY6@9]*JW'1)C*W2PL2!P[+4B508>CB>V:G_,^,2E*
M0%>W9\=C,3[.B;%HAEK\]$FI3XQ1<02S,S 6>7[DR.6E*R3L(0=K%'M(5&M@
M*GY(]D2.#)K>B /::I*_7;8DC(&2LG.W"W67*&3)"0?/LUGG%?8?DEH?D9%X
MZ6-)R\I6480XI]SQG*EY4WCS(M7;'U >><1Q1EV>25E 4:XAGEE/VA=[)+!3
ML#T&T5[32 G[I'.AOVS$_.OC>_9T!^WO^R8-<:0W-LE^3%K4?*RK\C[12!80
M:<L$BRP3AD1[\D+70SPX%SY>MA0=O.K;BU91AWUHSA>5BSF_+-!%C4R66EKR
M+YDQ\325RRN=<[3M' 8W/'4L;2H!H#T==2DJ2,&Y<4!&QR]M[(!^T;XGT-AR
MNR?QU=N@=MW=)<>'+R$N=#,R;^($=Z=L]?JK3#A^2Y="58@C-G/DMX68ZU_N
MC1JV)!Q8;H^#L+8Q\/\ AE>16KXJI15YXA&]W*F8NP@C4 Q5(6*JW#;@LS>0
ME25??4A:48]EW8GUH!%&R2?G^9[]D G7XZMSK_BQR4XNQR%B<F:I0J)-FS!L
MI7=G6>'>U;:VV7O!X$C5-DU&$@+J)+K<<9&2#$&EN9R0^ 6)(LN.(FNG?./5
M&R.4[2I4GC:*6#)BQ]'82,@<6KW)EDG,G'0,,+$J3KB=*.FRV/J1$7;,44+@
MGA;FA$<@V=H8Y0JR?&N(5C^W[AS_ &W-8ZT@*+>MOZ[37@W]OS$:-;8*DYG7
M]>0EBH!5CCBDZ\.L88DFNIS"IM4T/$^Z9#K!YQ]8"L<T-$-/MOO9&,Q%:"]E
M,0T/CRLD'U$57ZAJ,%BF)EFCH2V88)9*ADG=H]QE8V+1*[*@5(7;]'%0?6W<
M3)SKWI4VJJXBC>OY RP%PI,1:5B%')4;:*Y"A59-T\],?1T='2,>Y-V\[AN3
M:;N_M>R];A8E^H1HVR&9")V%89QV7@'$14=+PU8UI1;[9Y]9$ J, *' B%N!
MM0>"GLX&6\ZQD7?'Z?7L_F%RF,FI0":LB7OJGG4F:#[(Y46O6L,Y:#QQD$#7
MA'O3>L_[F[3LY7("]2DK1"2%%L^=I5)DB^Q7410REN47!2-#7C!WH^H2J_>,
MXM<=],U/C?M.0VIM6_Z_AVZ7(62GZRFJE#@APSZVZM^4C]Q$:\O81,1"MQ<<
M3\J:\^;D/!*6,H+6ENS?'5+W9_\ @IG;2V)DJBH;-:.1&@-:0&A.$N""7G7X
M0J>2JLX0C824@-_;F0L=O18X32"S:HKXRT2RK'+ H*+&QE5&'\@B,GB?:\P-
M^@F[N$[\XJ<M[W$;:U?.RE+O1-;A:Q>!K;&V%D"RL5Q+@$'+((B:A)K$EV('
M\?!%.+6L9R/K\2A+?S60K/RM7.)QN,H0/9R:4:HJ-8>**&>2.#2U2(VL*FH:
MX6 C89A$CJ"6(Z^9>[7R=Z>]&BU6L2<WB)9DYM[=N00';-]QV/6]?C?7H]L7
ME?8.)>X\0%BF!C-!;1*8B;9("S($A 4V:7G E5OI:!W?=6%-F*1$V)R81%+/
MA"<%DC%OP43A');M25UC#^*T^_%#:BDI32L%^X1+92(S\![9X?(@*J2P3WU'
MJ2/ VB>4+?U<6Y!#Z <@;*@>@>0&P=_(&WJ[IV?C2-WW98C9+,E&Z7XRRFX-
M9P*D8; B9G:%HN+UZ@AWDN(P['3UCU)1R1VG\MNQY]CFHX0M LO'-C=^*KM3
M6:NTG.O 9K%.$J0*QMNC3UP=G<2S()(E('A%B2O&1 L"I9S2\2[G9\<1<#1]
M[)V/R?>A_OWL[.QE#U?0;CR@VW8YBT3,L8@H@[8.V+\;\""AV)><#%*.?**R
MV%B9MELGHJK5S\B^%&.6*PQ698N)A&Y&1 ^VK24J=O(7)2(*5>2S:E"L[$1K
MLB.,,2\TSZC@A7[I)72)3L\NJ2*-[4W$?+MMB?0 9M>R?0V2![^-[.AO7=\D
MN1 <_&1VF]19Q7=-TD/$4W'Q/VA69STEX4XHM;R6"BXA<AG\KY-88-GIL\BR
MV=)=A*PH"AIP6K;)F,O'QO,C"AC^:RP86M)HK#"5^R2[*G%K]X O-*?'$4JQ
MQQ]=UF=0/IZYU GHD#B9F'RS?GCO^E3_ *S#D?4146BJF+#78FQ 6.RVFSJ'
M34M2TK+3FP+6HQI103LF60P<'18$L?+DA^0D@)&=,!4S*!UM<)(HLXU5<R4\
M[BCB85MW#)XC8=6>K#("0RHB%6MS1G>UC:.!&Y>6QY(WB8BB *F7?OVL*$<V
MWK7+UQC!'L,07(_R>)#=/_XI\,F*\RIJ\4FOV"Q'OBLO:JUX&4]KVOA/L,2>
M7-C3[QC]GVJ+G*6Q'B;U/LZ<!*DVUPY);&!GDV=7M2O$IR7<]M<A+7TY:_-&
MF,H*JJW-HR8J4;*OV%Q&BL&T[3-IC:5XY'80P0EGD8!88$9F8D E2%YRR_/P
MQ9?]WPV^G:8"A*UF%G)(<%AYW! ]8U\!'0<'6FE($(;CHF0="?9:0))M/E+'
M#B'@VW%^J/EGQ\?8>6LQ^I_;F+62GAZDF7D5B \1_A^+C(UZAD:-[,ZQN-@1
MP01.-&*<J0W3KCNRKUA%>]*E)#[\2CRV->O1 (CCWZ^7=E^"@.QU:S3>MZ76
M(LRS%0L1'P<+^2D13YUQV4R&2HI^9G; F3L1!RX=IM_+S[ZHUV/C6E87A P[
M$>,VRT_IME,_GXKG<&6^DQ^%C$L&.IUJZPPR2*_DN77L6&FMO'7XF%2UGP-*
MUC:*U=>,;N&EB<.L=.J&>PJ^>W:L2\C%&%)5- )$G+W(YX!D14^[BYZRM\O=
MSR_+GE/:+15QCI<&<GHS7^JH=EIS)95? *Q"UE@45?AUHNRR!#\ZZ&K.5,R4
MZ0/C/Q2G&,E[IRTO='<EFS65Y4GGCHXV(#[V@C;PUE53[#6)&:<H2>,D[*#H
M=>7\W?DS>8FFA#.LDJ5:48_J,2MXX0H/PTK$R%?P\K#?6N'C?J(;0VB]8:D8
M<9?>IE5  EBQ\82P?8B?G)6:09Q\4*]!U@-DBF,.8RYAEUM+BEK3E6?3^ Q:
MX7#8[%J59JE9$E=1I7L-N2S(OH'B\[R,N_?$@$D[/6V8JBN-QU.D-$UX55R/
MAI6V\S#^QI6=A^='W[ZFWJXZL.CHZ.HGWCK%_<>K;9KH2URU%/L(HB(ZY0*B
MD35;/"D0Y$>3C' I"**02A0F6?+4@/A33SJ'<NLK<8=K,SCCEL;9H)9EI/.J
M".W#R$U>1)$D62,I)$P8%->G7T2#L$@PLC3-^G-569Z[2A>$\?(21,KJX="K
M(=_;KTP]$[V-@Y*]SVG9&OMI2>C.;5-A.2M=IDRU&R0&U!')BWOU5]U+S,WJ
M_<N<A[2J"9J&>^]"$Q-J9 ;=?;;EXA]T8@-OSO)W)W+VSE9,5G7.6@IV )8,
M@#.\L&QQL4KT@^KA,L.GKR+*50E?)$60H,F_C><P5]Z.1E:['!*%DBM?S3+"
M3L206'_G*)(SRCW(4!(#QDAE$X6WL1:5Y"4*,W-P1Y%&1M=LPBSHZC[A#59(
ML _QX*KK]RK;0]GJQ,*_Y#. G*U>)1#R5*5)/M*9>>VVC!2R]"')8:Z9:TZ<
MD2<&4HP'WP.X(FCEC;:2++YV#?&QHG2:L5/)58[=";E#,-C?RI^&C< @HZ':
MLI^#OV002I';/:\YZZ*,/>*TE8;O'1RGFW+%I&09V4A;37G!#JZS7\HV3'C(
M1C*W')RC1:/3\EY\H2Y\:(6<?D9):):G=EB<I/2#Q2V89$^5FQUA8LA&X]:Y
MTQ\@@Z]]2+&%RM-%F>M+X67FD\8+Q2*1Z*3Q\XVW_8_X_'QU&^.5VXA:Q-TF
MZ_F)J<C=8;"TH^-8W#0YMZB7 &,5FES*) =PH-W7UCKL1=:8.2,ET#($_4&4
M##V*,5"<2#C><WDDEA+QP:F:1IHQ8DAA\,KN6=HQ-X)$DE7RPNDBSN\4IDK=
M F=@T<GIPDB[/HE2NRI]>B./(?N 1K9]MFH&GZOK_LGR.T("-&;M6Q)2S;0V
MC8,-)469#P%BVIIJA5PPK/E:8"'GOZ?-:%7C(P$Y8)&2=3A>7'<0,_>:0#MZ
M! 9E3MW.66'];5CW95I2>_1"55A%B0  !7)/R.KFO1$>!.3/Q):LUO>M;2H[
M(/C?W%M#?P=Z!]])\H>@+PI-0AZW2Y;9G([;46W*:FU'$1[L@NGU0GX85NK:
M3;[*!8B):'6B0IL9/.CQ#K;C5XMCS-8 #C;/47<G-E[,]#&.(<70+#+Y8N(8
MF: :FI5YW*)%'"!K(76=5A!^FC=9F>6*LKU'W&!&\UJ;7T]=%+LO+XD= "23
MO<2?D_<PX@!]._ OMV4'BE6<6*] AWS>=KCFW-B6V0D'YC+QYF4&2<%%'*^.
M H!B2PIQ]V/=(F+,:R/8#;$'A $!$+US]2,%VY$]3MRE'EKX3Q29&8/#CHRN
MAXZT8"3V($9>/%!520!76>1>(70L/V+8D"S9.7Z8-]QBCXO8;?LAF.XX?_"1
MOPRJ?AEOL2VQ]008..!PM+N(^,#'C@<.H9;&0\H81MIMXC [++&2W\.EN---
MI=?<^.,]9'G>Z,[W'+Y,MD)9XU;E%534-*#\#PU8@L*D+I?(5:9@!Y)'/OK1
M*&+H8U.%.ND1(TTFN4S_ !OG*VW(.M\00@/]*CKMZ31S;24EYU+@T*PYC[1G
MCXY>RG.,J%$^6/"WE?X6YXRV.G.5K^2_6TXR]A?I_?[OMI/,DM3 P2#ZN\5X
MFP4/W5*)8$23M_3)* T=927DY2>.&6OSN>@Q,1C0K+>D7^5#O8C!'J6;7M4'
MRJ^FE/I=+R=5?]U+G)$0<!)\3-,2C+AQ3&(K;L_$OX4-"Q+>,8<UT 4TK/ME
M)#XI3<%H<RD(#YUXA1!DC,CQFL?J!W13QE!>S>WQ'###"E6^:_J.M6C 5<=$
MP)+2N!_RQB20NX7+R2S"/RWWSW0TK3XVO.9K%AF.3L @Z#';5@1ZYN?\>%TJ
M)_)T>3JG ]H+AX=,3[7*N]!D#0$%F1C=4QS[>$-STXK#L;*VU>/;\G8V Q@R
M,C&W1O43...'L/(<@F_=T_I;VJ\TX[ENHRP0&2/&1L !/-[CDM'WLQP??'&&
M733[D4@PC<'L?!,\HS-E2(H^:4D(]2R>T>?Y]I%]R)L>Y?O4@Q#>C+K>>M2Z
M.CHZ.CHZ.CHZH3SIX,U'E]3F2Q'A*QN"J D-TFXN-*^J8.I3A.:G:L,(6037
MC"5K=&*:0\;7CGW9&/:(9(E(N52N\NSJO=-165EK96LC"G;(^UEV6^FL\06:
MNS$E6 +P.QDC#!I(I5ON+MV#.0!E*PWH5/T]C7IA[/@FT-M$Q.P1MHF)= 07
M1\[6F=\\DNW'N.=JTM!G --'LM; U19G'FX"SB-YRV/,Q!K&"&!S'A4Y<@+E
M"?;&*']27T2\7[ ',(Q.:[@[!RTU:6%TTX%[&6"1!93X6:)UY*KE1N"W#S5E
MUL2Q;C.7T,EE>U;\D+QLNF LTIB1',OXD1AR 8C_ !5B/D"-;$B;4Z-]%\I>
M-O,V'&<I]B:@]A-"8<D*/-O"1-\B5M(^;_H#4ZH>T1#&?YXDX9R0%9:<;P4J
M+-=<%;U*S4['_5&NCEC3S<<8"R(T=?+URHWQ*D-'D*J'V"!*L:D\'K2NVMQ[
M5[[CD4"A94\O<^+MD!@2/O*)O9]?,L#%2->4;' 53[BO;18Y8:GLSM9B*W_J
M$KD8@_4FT,I;C)8@N+=0_B@7HOXX(EJ=8@TDQ@/W'I--.F"19V,^J+^:$D>C
M#]L=UX%I\7D+ [BPLH!Q^169Q?QLBG[8[56=S.]"<?:\-6:ZU60)/ B@RD,.
M<DP^;A%JM"F.RD?MHV74-H?)"S1+Q$B^]/*D/,$@L2$Z1KQ+YCNZ(X5\N.$'
M)Z"$I.^>-\/:#H"C;. '<C+S1+/L>OSMXHRX][V"R<O"R$]8Y^+1&ND(L58M
MD?/UE:@ZZ_)K^9'&2R-=R!GFJ9NG@K^$T" T]7(78)$E1@>(EH>:V\/ID9IJ
MTRE5A&U^IDW@Q5C$2QKP^JCMH&T0I1&610#\^0>/\C[58;/,Z<3V\]%IU3QT
MI-PL##TUO+?=9K^W-VWN2;R3:)^=O(:+?%54@M2,O@UVB1DV+!QE9#4U#!2@
M\M+,"I+E"',XWWODK(LIVCBHG@Q>*2!):M9&)N7C&LTC3\ 6E2J\I@AC;DHD
M26R>4TS,--[/Q<%7'Q92SQ>]>4RF:4KN*)F(2.,G07DHY,1HD$+\+KIA,;2[
M1*J3@2%.PA7CP^2UD,?QG_*L/%>E"\8Q^\X;RM6?\83G/ZZHL7V)W=F&44\#
M?"-K4]N$T:^C\L)[A@C< >R(R[?@*6(!8+.<Q-0'S7H"P^4B?SR;_8I#S8'_
M %@ /R0.N[>IE/U_"&7+:UK@X&OQ#7VI$R5E!H6 !;QG'C,A+R#HJ,X6K.$(
M91EC+KN4MMJ>RO"%;#@/T<QN*C&3[SR5>6. "1Z<$QKX]->Q]7=E\,LP_!BB
M6NO(:\LR-Q*3F.^1'#(:G"E H/.[;:-65?C:*6,49_9G:0G?I5;1Z35S1[M3
M,A&R>J.);A45&.,NQ<OM]0KL46H3.%-/"ZZBWFV2XM#C><M8M,BP+(M84ZJ%
MC@GT!3G4CN?]2((JW\%[1C6I5C3Z<WXHA75(@"OBQL 5# NO0L.B.OW>&)&X
M3]>?NX^^7L&6#%2R,TA;SY*0MY7W_5]/S^\$^P9Y '^?&H/&3JL/ SMTW'DU
M.@[-VN),5K1XQF#W3"\D!SVT"4N^UR.K[CWQ+;@WW/EB9MF/XKQET"$=(DLE
MF0]#V5V';[BG3(9-9:^&5^9=BR3Y)M[,<!/WB%C_ (ZUL;V4@9I.;PTG;G:U
MC+R+;NK)%C@W(LVUEN-O?"(G[A&3_C)_S[2(E^31ZJH&!AJO"1-;KD6#"0$%
M'!Q,-$1H[8D?&1@#"!@@0QF4I:8'&8;0TTVA.,)0G&.O2<$$-:&*O7B2&""-
M(H8HU"1QQHH5$11H*JJ  !\ =;)'''#&D42+'%&BI'&@"JB* %50/0    Z]
M;KMZY]'1T='1T='1T='1T=5UY$\5]+\H:RFO;6J[9Q83+Z*_;8M:(VX5=U_]
MK=A9I+3JL,J<PEU^*D&)"%,=0VX;&D+::4BASW;6([CKB#)U@[H"(+41$=NN
M6^3#-Q;[=^S%(LD+$ O&Q U5Y3#T,Q#XKL(8J#XITTD\)/R8Y-'UO1*.&C8@
M%D;0UGCW_P!IODAI:3>M6F"']P5B.)_(1I=44J&V5">A?N'<>K6"</R!@R\-
MH'*J)\H:0ZC)7XJ-3X;1A6<_3+/XB0V<2S96M&W.-ZW\G(0\3M2:_/E(RG05
MJKRNQ'+Q1CT,OR?9>5H.9J!-^%3R1H?Y=N/7L$P\ML5.@&@9V)^[@GP.$UUW
M,>;6@#,U&WS+MR1#*2,35MW5R1*L,?\ '^*VB9GWP%W^Q\<8PC$S+'H9RE.<
M#Y3\T+AT/U"[OPC?2VIC;\6E:MF*\CSQZ]$--R@N<M?'FE< ^^/R#'J]V=P8
MQO!/(9Q'I3#D(F:5=>B#)N*QRU_\21@#[U\[@?N(ZZ.[HVG)GEWJ760D1R;X
M\_7KVY-=4LUR6D-B:*?C")"'V-&QSS0TJ?*T2:;F8<^.%:ESWJN8A+II&(J$
MCTZ'B\X.]Z%FTM6*KE<;(J35H93(9Z<B I80.JN.,HD1D'DTH +,SQJKSA\U
M_A!7GD,25[=5U62&.0N9(&4%9E#!6&G#H5^[0 VXY !G>HN^'JQ7'S3I]'U)
M)W8^(U[4:G?8]NY UO-&V%!PR8J2K$H+FO31: #\13LU49YMA499()US :T3
M,)9X:#L\]^H*8%*I7#RW8IX@/.EM(84LJ"):TA$$[+(H =#HK+$P:,DI(J=N
M8[H_@W@!Q\EF.6,<9A.L:"9=AX7_ )4A5P '!T0ZMM=E7"Q5L7O7[\L+#XFN
M==Z^URT^E242$BN3O4Z)Y\_%8I!>8*"RXG]>?N5LUM6<?^EC&?'2#?\ U=S<
MX9:%"C0#;U)(9+LZ?L59_#!L?Z==P?V'2C:[_P E*"M6K5J@[^]B]B1?VXEO
M''O_ %HF']G51@JASIY\V$>3?%V9MAC!"E,3LZY^"UK *<7ZR%1Y)?X:BPRT
MI4M;H$(TT>0VASTA$K3E/2NE7O+O:=9&7(Y->6UFG/AQ\!)XL49O%2A(V2R0
M .P!XHQ&NJ18.XNY)0Y%NZ-^I)#XZD6_1XEO'6C]'92,!B-Z4].0XE]H:B:L
MD82_[^F -GW2-<'D J5'C+_MQ"R+*_8TN1R>RV?=71EI:<:;/#B87V>UHN'E
M&\,OXU;MC]+J6-DAO9N5,C;C*NE.-2*$,@]@R<P)+A4Z*\UAAWL/#(--T]X7
MLBM3>.SDI%N6$(9:ZJ?I(V'L%N0#6"I]CDL<?X:-] ].9;;;:;0TTA#332$M
MMMMI2AMMM"<)0A"$XPE"$)QA*4IQA*4XQC&,8QUK          &@ /0  ]
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M;:<)0VVVC&$(0A.,)0A.,)2G&,8QC&,8Z8@ H"J  !H    #X  ] #]AU;
@     : 'H #X 'X Z^SK[U]Z.CHZ.CHZ.CHZ.CHZ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g621396g01a02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g621396g01a02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C '0# 1$  A$! Q$!_\0
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MW$[4[3@ZJ7JG2(<[6K+!E$L#R [!2GH.WU.80D=YX(AT;+@Q"4LE!%L$1Y[
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MB;0R=N)B&8LI^^G7<%8$!*2R*;!Y@5S'Z7?!+2[6RMZT@-R>@YC1E]UHF*Z
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MJBIT&P&<O9)\OC8TG>1LA2BKVWB@BGD$^F:+F*[I_5"9N(XL1QX/U^N2J4?
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MQ^_EB  8_N9(RDA/QR8@?'6=TYO- C'^I?L?_67\_P"\:/\ >2/QTFWL9_\
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MQPUZJ*9@#L,X?>@K!D^WJ']1]OJ*T;<MI[ UKR+WI"6W<\D],[!E2(_1LO\
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MMMMI2AMMM"<)0A"$XPE"$)QA*4IQA*4XQC&,8QUK          &@ /0  ]
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M;:<)0VVVC&$(0A.,)0A.,)2G&,8QC&,8Z8@ H"J  !H    #X  ] #]AU;
@     : 'H #X 'X Z^SK[U]Z.CHZ.CHZ.CHZ.CHZ_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
